CN108728477A - A kind of efficient Transpositional mutation system and construction method - Google Patents
A kind of efficient Transpositional mutation system and construction method Download PDFInfo
- Publication number
- CN108728477A CN108728477A CN201710270598.XA CN201710270598A CN108728477A CN 108728477 A CN108728477 A CN 108728477A CN 201710270598 A CN201710270598 A CN 201710270598A CN 108728477 A CN108728477 A CN 108728477A
- Authority
- CN
- China
- Prior art keywords
- plasmid
- gene
- transpositional
- promoter
- mutation system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000035772 mutation Effects 0.000 title claims abstract description 66
- 238000010276 construction Methods 0.000 title abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 70
- 239000000126 substance Substances 0.000 claims abstract description 29
- 102000004190 Enzymes Human genes 0.000 claims abstract description 17
- 108090000790 Enzymes Proteins 0.000 claims abstract description 17
- 239000013612 plasmid Substances 0.000 claims description 107
- 108010020764 Transposases Proteins 0.000 claims description 61
- 102000008579 Transposases Human genes 0.000 claims description 58
- 230000014509 gene expression Effects 0.000 claims description 45
- 210000005253 yeast cell Anatomy 0.000 claims description 32
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 27
- 241000235058 Komagataella pastoris Species 0.000 claims description 24
- 101710117021 Tyrosine-protein phosphatase YopH Proteins 0.000 claims description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- 239000002773 nucleotide Substances 0.000 claims description 21
- 125000003729 nucleotide group Chemical group 0.000 claims description 21
- 230000001939 inductive effect Effects 0.000 claims description 17
- 101100389345 Bacillus subtilis (strain 168) ndoA gene Proteins 0.000 claims description 15
- 101150048352 mazF gene Proteins 0.000 claims description 15
- 230000010076 replication Effects 0.000 claims description 14
- 101150069554 HIS4 gene Proteins 0.000 claims description 13
- 210000004027 cell Anatomy 0.000 claims description 13
- 206010064571 Gene mutation Diseases 0.000 claims description 10
- 230000006698 induction Effects 0.000 claims description 9
- 108010084455 Zeocin Proteins 0.000 claims description 7
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 claims description 7
- 101000695548 Homo sapiens Probable proline-tRNA ligase, mitochondrial Proteins 0.000 claims description 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 6
- 102100028531 Probable proline-tRNA ligase, mitochondrial Human genes 0.000 claims description 6
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 6
- 229930189065 blasticidin Natural products 0.000 claims description 6
- 229930182817 methionine Natural products 0.000 claims description 6
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 6
- 229960003495 thiamine Drugs 0.000 claims description 6
- 235000019157 thiamine Nutrition 0.000 claims description 6
- 239000011721 thiamine Substances 0.000 claims description 6
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 3
- 241000235648 Pichia Species 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 238000005516 engineering process Methods 0.000 abstract description 6
- 210000000349 chromosome Anatomy 0.000 abstract description 4
- 108020004414 DNA Proteins 0.000 description 66
- 230000001580 bacterial effect Effects 0.000 description 25
- 238000000034 method Methods 0.000 description 20
- 235000013339 cereals Nutrition 0.000 description 17
- 240000007019 Oxalis corniculata Species 0.000 description 15
- 230000017105 transposition Effects 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 12
- 230000010354 integration Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 150000007523 nucleic acids Chemical group 0.000 description 9
- 238000012216 screening Methods 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 238000011081 inoculation Methods 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 7
- 238000012795 verification Methods 0.000 description 7
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000002703 mutagenesis Methods 0.000 description 5
- 231100000350 mutagenesis Toxicity 0.000 description 5
- 108010006654 Bleomycin Proteins 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 229960001561 bleomycin Drugs 0.000 description 4
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- 230000005611 electricity Effects 0.000 description 4
- 108010034529 leucyl-lysine Proteins 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 102000007469 Actins Human genes 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 3
- 230000026774 DNA mediated transformation Effects 0.000 description 3
- 206010011968 Decreased immune responsiveness Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 101150063416 add gene Proteins 0.000 description 3
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 108010038633 aspartylglutamate Proteins 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 230000024540 transposon integration Effects 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- XCIGOVDXZULBBV-DCAQKATOSA-N Ala-Val-Lys Chemical compound CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(O)=O XCIGOVDXZULBBV-DCAQKATOSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- JDHOJQJMWBKHDB-CIUDSAMLSA-N Asp-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N JDHOJQJMWBKHDB-CIUDSAMLSA-N 0.000 description 2
- RSMZEHCMIOKNMW-GSSVUCPTSA-N Asp-Thr-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RSMZEHCMIOKNMW-GSSVUCPTSA-N 0.000 description 2
- 101710140859 E3 ubiquitin ligase TRAF3IP2 Proteins 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- MHXKHKWHPNETGG-QWRGUYRKSA-N Gly-Lys-Leu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O MHXKHKWHPNETGG-QWRGUYRKSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- VCSBGUACOYUIGD-CIUDSAMLSA-N Leu-Asn-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VCSBGUACOYUIGD-CIUDSAMLSA-N 0.000 description 2
- WGNOPSQMIQERPK-UHFFFAOYSA-N Leu-Asn-Pro Natural products CC(C)CC(N)C(=O)NC(CC(=O)N)C(=O)N1CCCC1C(=O)O WGNOPSQMIQERPK-UHFFFAOYSA-N 0.000 description 2
- SJNZALDHDUYDBU-IHRRRGAJSA-N Lys-Arg-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(O)=O SJNZALDHDUYDBU-IHRRRGAJSA-N 0.000 description 2
- RBEATVHTWHTHTJ-KKUMJFAQSA-N Lys-Leu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O RBEATVHTWHTHTJ-KKUMJFAQSA-N 0.000 description 2
- SBQDRNOLGSYHQA-YUMQZZPRSA-N Lys-Ser-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SBQDRNOLGSYHQA-YUMQZZPRSA-N 0.000 description 2
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 2
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 2
- 101150111072 Pars2 gene Proteins 0.000 description 2
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 2
- 241000254113 Tribolium castaneum Species 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 210000005056 cell body Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 108010015792 glycyllysine Proteins 0.000 description 2
- 108010085325 histidylproline Proteins 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 108010017391 lysylvaline Proteins 0.000 description 2
- 238000010422 painting Methods 0.000 description 2
- 108010085336 phosphoribosyl-AMP cyclohydrolase Proteins 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical class [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 1
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 1
- OBVSBEYOMDWLRJ-BFHQHQDPSA-N Ala-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N OBVSBEYOMDWLRJ-BFHQHQDPSA-N 0.000 description 1
- DPNZTBKGAUAZQU-DLOVCJGASA-N Ala-Leu-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N DPNZTBKGAUAZQU-DLOVCJGASA-N 0.000 description 1
- SDZRIBWEVVRDQI-CIUDSAMLSA-N Ala-Lys-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O SDZRIBWEVVRDQI-CIUDSAMLSA-N 0.000 description 1
- NHWYNIZWLJYZAG-XVYDVKMFSA-N Ala-Ser-His Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N NHWYNIZWLJYZAG-XVYDVKMFSA-N 0.000 description 1
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 1
- SAHQGRZIQVEJPF-JXUBOQSCSA-N Ala-Thr-Lys Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN SAHQGRZIQVEJPF-JXUBOQSCSA-N 0.000 description 1
- ZCUFMRIQCPNOHZ-NRPADANISA-N Ala-Val-Gln Chemical compound C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N ZCUFMRIQCPNOHZ-NRPADANISA-N 0.000 description 1
- NLYYHIKRBRMAJV-AEJSXWLSSA-N Ala-Val-Pro Chemical compound C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N NLYYHIKRBRMAJV-AEJSXWLSSA-N 0.000 description 1
- SGYSTDWPNPKJPP-GUBZILKMSA-N Arg-Ala-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SGYSTDWPNPKJPP-GUBZILKMSA-N 0.000 description 1
- SLNCSSWAIDUUGF-LSJOCFKGSA-N Arg-His-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O SLNCSSWAIDUUGF-LSJOCFKGSA-N 0.000 description 1
- GNYUVVJYGJFKHN-RVMXOQNASA-N Arg-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N GNYUVVJYGJFKHN-RVMXOQNASA-N 0.000 description 1
- LLUGJARLJCGLAR-CYDGBPFRSA-N Arg-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N LLUGJARLJCGLAR-CYDGBPFRSA-N 0.000 description 1
- YKZJPIPFKGYHKY-DCAQKATOSA-N Arg-Leu-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YKZJPIPFKGYHKY-DCAQKATOSA-N 0.000 description 1
- CLICCYPMVFGUOF-IHRRRGAJSA-N Arg-Lys-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O CLICCYPMVFGUOF-IHRRRGAJSA-N 0.000 description 1
- BTJVOUQWFXABOI-IHRRRGAJSA-N Arg-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(N)=N BTJVOUQWFXABOI-IHRRRGAJSA-N 0.000 description 1
- XKDYWGLNSCNRGW-WDSOQIARSA-N Arg-Lys-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCN=C(N)N)CCCCN)C(O)=O)=CNC2=C1 XKDYWGLNSCNRGW-WDSOQIARSA-N 0.000 description 1
- PAPSMOYMQDWIOR-AVGNSLFASA-N Arg-Lys-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PAPSMOYMQDWIOR-AVGNSLFASA-N 0.000 description 1
- AWMAZIIEFPFHCP-RCWTZXSCSA-N Arg-Pro-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O AWMAZIIEFPFHCP-RCWTZXSCSA-N 0.000 description 1
- FRBAHXABMQXSJQ-FXQIFTODSA-N Arg-Ser-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O FRBAHXABMQXSJQ-FXQIFTODSA-N 0.000 description 1
- ZPWMEWYQBWSGAO-ZJDVBMNYSA-N Arg-Thr-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZPWMEWYQBWSGAO-ZJDVBMNYSA-N 0.000 description 1
- YHZQOSXDTFRZKU-WDSOQIARSA-N Arg-Trp-Leu Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N)=CNC2=C1 YHZQOSXDTFRZKU-WDSOQIARSA-N 0.000 description 1
- UVTGNSWSRSCPLP-UHFFFAOYSA-N Arg-Tyr Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O UVTGNSWSRSCPLP-UHFFFAOYSA-N 0.000 description 1
- XYOVHPDDWCEUDY-CIUDSAMLSA-N Asn-Ala-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O XYOVHPDDWCEUDY-CIUDSAMLSA-N 0.000 description 1
- LXTGAOAXPSJWOU-DCAQKATOSA-N Asn-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)N)N LXTGAOAXPSJWOU-DCAQKATOSA-N 0.000 description 1
- MFFOYNGMOYFPBD-DCAQKATOSA-N Asn-Arg-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O MFFOYNGMOYFPBD-DCAQKATOSA-N 0.000 description 1
- IOTKDTZEEBZNCM-UGYAYLCHSA-N Asn-Asn-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOTKDTZEEBZNCM-UGYAYLCHSA-N 0.000 description 1
- APHUDFFMXFYRKP-CIUDSAMLSA-N Asn-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N APHUDFFMXFYRKP-CIUDSAMLSA-N 0.000 description 1
- XQQVCUIBGYFKDC-OLHMAJIHSA-N Asn-Asp-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XQQVCUIBGYFKDC-OLHMAJIHSA-N 0.000 description 1
- PPMTUXJSQDNUDE-CIUDSAMLSA-N Asn-Glu-Arg Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PPMTUXJSQDNUDE-CIUDSAMLSA-N 0.000 description 1
- DMLSCRJBWUEALP-LAEOZQHASA-N Asn-Glu-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O DMLSCRJBWUEALP-LAEOZQHASA-N 0.000 description 1
- HYQYLOSCICEYTR-YUMQZZPRSA-N Asn-Gly-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O HYQYLOSCICEYTR-YUMQZZPRSA-N 0.000 description 1
- PNHQRQTVBRDIEF-CIUDSAMLSA-N Asn-Leu-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)N PNHQRQTVBRDIEF-CIUDSAMLSA-N 0.000 description 1
- UHGUKCOQUNPSKK-CIUDSAMLSA-N Asn-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)N)N UHGUKCOQUNPSKK-CIUDSAMLSA-N 0.000 description 1
- GLWFAWNYGWBMOC-SRVKXCTJSA-N Asn-Leu-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O GLWFAWNYGWBMOC-SRVKXCTJSA-N 0.000 description 1
- YVXRYLVELQYAEQ-SRVKXCTJSA-N Asn-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N YVXRYLVELQYAEQ-SRVKXCTJSA-N 0.000 description 1
- FHETWELNCBMRMG-HJGDQZAQSA-N Asn-Leu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FHETWELNCBMRMG-HJGDQZAQSA-N 0.000 description 1
- PPCORQFLAZWUNO-QWRGUYRKSA-N Asn-Phe-Gly Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC(=O)N)N PPCORQFLAZWUNO-QWRGUYRKSA-N 0.000 description 1
- PLTGTJAZQRGMPP-FXQIFTODSA-N Asn-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O PLTGTJAZQRGMPP-FXQIFTODSA-N 0.000 description 1
- NJSNXIOKBHPFMB-GMOBBJLQSA-N Asn-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)N)N NJSNXIOKBHPFMB-GMOBBJLQSA-N 0.000 description 1
- HNXWVVHIGTZTBO-LKXGYXEUSA-N Asn-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O HNXWVVHIGTZTBO-LKXGYXEUSA-N 0.000 description 1
- HCZQKHSRYHCPSD-IUKAMOBKSA-N Asn-Thr-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HCZQKHSRYHCPSD-IUKAMOBKSA-N 0.000 description 1
- RDLYUKRPEJERMM-XIRDDKMYSA-N Asn-Trp-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(O)=O RDLYUKRPEJERMM-XIRDDKMYSA-N 0.000 description 1
- YNQMEIJEWSHOEO-SRVKXCTJSA-N Asn-Tyr-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O YNQMEIJEWSHOEO-SRVKXCTJSA-N 0.000 description 1
- CBHVAFXKOYAHOY-NHCYSSNCSA-N Asn-Val-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O CBHVAFXKOYAHOY-NHCYSSNCSA-N 0.000 description 1
- QRULNKJGYQQZMW-ZLUOBGJFSA-N Asp-Asn-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O QRULNKJGYQQZMW-ZLUOBGJFSA-N 0.000 description 1
- IJHUZMGJRGNXIW-CIUDSAMLSA-N Asp-Glu-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IJHUZMGJRGNXIW-CIUDSAMLSA-N 0.000 description 1
- ZEDBMCPXPIYJLW-XHNCKOQMSA-N Asp-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O ZEDBMCPXPIYJLW-XHNCKOQMSA-N 0.000 description 1
- DTNUIAJCPRMNBT-WHFBIAKZSA-N Asp-Gly-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(O)=O DTNUIAJCPRMNBT-WHFBIAKZSA-N 0.000 description 1
- KPNUCOPMVSGRCR-DCAQKATOSA-N Asp-His-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O KPNUCOPMVSGRCR-DCAQKATOSA-N 0.000 description 1
- GBSUGIXJAAKZOW-GMOBBJLQSA-N Asp-Ile-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O GBSUGIXJAAKZOW-GMOBBJLQSA-N 0.000 description 1
- YFSLJHLQOALGSY-ZPFDUUQYSA-N Asp-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N YFSLJHLQOALGSY-ZPFDUUQYSA-N 0.000 description 1
- PYXXJFRXIYAESU-PCBIJLKTSA-N Asp-Ile-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PYXXJFRXIYAESU-PCBIJLKTSA-N 0.000 description 1
- OEDJQRXNDRUGEU-SRVKXCTJSA-N Asp-Leu-His Chemical compound N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O OEDJQRXNDRUGEU-SRVKXCTJSA-N 0.000 description 1
- QNMKWNONJGKJJC-NHCYSSNCSA-N Asp-Leu-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O QNMKWNONJGKJJC-NHCYSSNCSA-N 0.000 description 1
- JSNWZMFSLIWAHS-HJGDQZAQSA-N Asp-Thr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O JSNWZMFSLIWAHS-HJGDQZAQSA-N 0.000 description 1
- NWAHPBGBDIFUFD-KKUMJFAQSA-N Asp-Tyr-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O NWAHPBGBDIFUFD-KKUMJFAQSA-N 0.000 description 1
- KLLFLHBKSJAUMZ-ACZMJKKPSA-N Cys-Asn-Glu Chemical compound C(CC(=O)O)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)N KLLFLHBKSJAUMZ-ACZMJKKPSA-N 0.000 description 1
- ZIKWRNJXFIQECJ-CIUDSAMLSA-N Cys-Cys-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O ZIKWRNJXFIQECJ-CIUDSAMLSA-N 0.000 description 1
- BSFFNUBDVYTDMV-WHFBIAKZSA-N Cys-Gly-Asn Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O BSFFNUBDVYTDMV-WHFBIAKZSA-N 0.000 description 1
- OZHXXYOHPLLLMI-CIUDSAMLSA-N Cys-Lys-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OZHXXYOHPLLLMI-CIUDSAMLSA-N 0.000 description 1
- NGOIQDYZMIKCOK-NAKRPEOUSA-N Cys-Val-Ile Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NGOIQDYZMIKCOK-NAKRPEOUSA-N 0.000 description 1
- 102100026620 E3 ubiquitin ligase TRAF3IP2 Human genes 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 240000005708 Eugenia stipitata Species 0.000 description 1
- 235000006149 Eugenia stipitata Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- NNQHEEQNPQYPGL-FXQIFTODSA-N Gln-Ala-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O NNQHEEQNPQYPGL-FXQIFTODSA-N 0.000 description 1
- SNLOOPZHAQDMJG-CIUDSAMLSA-N Gln-Glu-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SNLOOPZHAQDMJG-CIUDSAMLSA-N 0.000 description 1
- NSORZJXKUQFEKL-JGVFFNPUSA-N Gln-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCC(=O)N)N)C(=O)O NSORZJXKUQFEKL-JGVFFNPUSA-N 0.000 description 1
- KHGGWBRVRPHFMH-PEFMBERDSA-N Gln-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N KHGGWBRVRPHFMH-PEFMBERDSA-N 0.000 description 1
- HHQCBFGKQDMWSP-GUBZILKMSA-N Gln-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)N)N HHQCBFGKQDMWSP-GUBZILKMSA-N 0.000 description 1
- VUVKKXPCKILIBD-AVGNSLFASA-N Gln-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCC(=O)N)N VUVKKXPCKILIBD-AVGNSLFASA-N 0.000 description 1
- PSERKXGRRADTKA-MNXVOIDGSA-N Gln-Leu-Ile Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PSERKXGRRADTKA-MNXVOIDGSA-N 0.000 description 1
- MLSKFHLRFVGNLL-WDCWCFNPSA-N Gln-Leu-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MLSKFHLRFVGNLL-WDCWCFNPSA-N 0.000 description 1
- XBWGJWXGUNSZAT-CIUDSAMLSA-N Gln-Met-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N XBWGJWXGUNSZAT-CIUDSAMLSA-N 0.000 description 1
- CGYDXNKRIMJMLV-GUBZILKMSA-N Glu-Arg-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O CGYDXNKRIMJMLV-GUBZILKMSA-N 0.000 description 1
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 1
- RJONUNZIMUXUOI-GUBZILKMSA-N Glu-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N RJONUNZIMUXUOI-GUBZILKMSA-N 0.000 description 1
- LXAUHIRMWXQRKI-XHNCKOQMSA-N Glu-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N)C(=O)O LXAUHIRMWXQRKI-XHNCKOQMSA-N 0.000 description 1
- JPHYJQHPILOKHC-ACZMJKKPSA-N Glu-Asp-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O JPHYJQHPILOKHC-ACZMJKKPSA-N 0.000 description 1
- XKPOCESCRTVRPL-KBIXCLLPSA-N Glu-Cys-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XKPOCESCRTVRPL-KBIXCLLPSA-N 0.000 description 1
- WPLGNDORMXTMQS-FXQIFTODSA-N Glu-Gln-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O WPLGNDORMXTMQS-FXQIFTODSA-N 0.000 description 1
- HTTSBEBKVNEDFE-AUTRQRHGSA-N Glu-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)N HTTSBEBKVNEDFE-AUTRQRHGSA-N 0.000 description 1
- NKLRYVLERDYDBI-FXQIFTODSA-N Glu-Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NKLRYVLERDYDBI-FXQIFTODSA-N 0.000 description 1
- AUTNXSQEVVHSJK-YVNDNENWSA-N Glu-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O AUTNXSQEVVHSJK-YVNDNENWSA-N 0.000 description 1
- XMPAXPSENRSOSV-RYUDHWBXSA-N Glu-Gly-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O XMPAXPSENRSOSV-RYUDHWBXSA-N 0.000 description 1
- ZHNHJYYFCGUZNQ-KBIXCLLPSA-N Glu-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O ZHNHJYYFCGUZNQ-KBIXCLLPSA-N 0.000 description 1
- RBXSZQRSEGYDFG-GUBZILKMSA-N Glu-Lys-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O RBXSZQRSEGYDFG-GUBZILKMSA-N 0.000 description 1
- PMSMKNYRZCKVMC-DRZSPHRISA-N Glu-Phe-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(=O)O)N PMSMKNYRZCKVMC-DRZSPHRISA-N 0.000 description 1
- CBWKURKPYSLMJV-SOUVJXGZSA-N Glu-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(=O)O)N)C(=O)O CBWKURKPYSLMJV-SOUVJXGZSA-N 0.000 description 1
- GPSHCSTUYOQPAI-JHEQGTHGSA-N Glu-Thr-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O GPSHCSTUYOQPAI-JHEQGTHGSA-N 0.000 description 1
- DTLLNDVORUEOTM-WDCWCFNPSA-N Glu-Thr-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DTLLNDVORUEOTM-WDCWCFNPSA-N 0.000 description 1
- PMSDOVISAARGAV-FHWLQOOXSA-N Glu-Tyr-Phe Chemical compound C([C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 PMSDOVISAARGAV-FHWLQOOXSA-N 0.000 description 1
- YMUFWNJHVPQNQD-ZKWXMUAHSA-N Gly-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN YMUFWNJHVPQNQD-ZKWXMUAHSA-N 0.000 description 1
- MHHUEAIBJZWDBH-YUMQZZPRSA-N Gly-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN MHHUEAIBJZWDBH-YUMQZZPRSA-N 0.000 description 1
- SABZDFAAOJATBR-QWRGUYRKSA-N Gly-Cys-Phe Chemical compound [H]NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SABZDFAAOJATBR-QWRGUYRKSA-N 0.000 description 1
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 1
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 1
- AYBKPDHHVADEDA-YUMQZZPRSA-N Gly-His-Asn Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O AYBKPDHHVADEDA-YUMQZZPRSA-N 0.000 description 1
- JQFILXICXLDTRR-FBCQKBJTSA-N Gly-Thr-Gly Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)NCC(O)=O JQFILXICXLDTRR-FBCQKBJTSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- JWTKVPMQCCRPQY-SRVKXCTJSA-N His-Asn-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JWTKVPMQCCRPQY-SRVKXCTJSA-N 0.000 description 1
- STWGDDDFLUFCCA-GVXVVHGQSA-N His-Glu-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O STWGDDDFLUFCCA-GVXVVHGQSA-N 0.000 description 1
- OEROYDLRVAYIMQ-YUMQZZPRSA-N His-Gly-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O OEROYDLRVAYIMQ-YUMQZZPRSA-N 0.000 description 1
- BRZQWIIFIKTJDH-VGDYDELISA-N His-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N BRZQWIIFIKTJDH-VGDYDELISA-N 0.000 description 1
- VFBZWZXKCVBTJR-SRVKXCTJSA-N His-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N VFBZWZXKCVBTJR-SRVKXCTJSA-N 0.000 description 1
- RNMNYMDTESKEAJ-KKUMJFAQSA-N His-Leu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CN=CN1 RNMNYMDTESKEAJ-KKUMJFAQSA-N 0.000 description 1
- CUEQQFOGARVNHU-VGDYDELISA-N His-Ser-Ile Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O CUEQQFOGARVNHU-VGDYDELISA-N 0.000 description 1
- HDODQNPMSHDXJT-GHCJXIJMSA-N Ile-Asn-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O HDODQNPMSHDXJT-GHCJXIJMSA-N 0.000 description 1
- NKRJALPCDNXULF-BYULHYEWSA-N Ile-Asp-Gly Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O NKRJALPCDNXULF-BYULHYEWSA-N 0.000 description 1
- LPXHYGGZJOCAFR-MNXVOIDGSA-N Ile-Glu-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N LPXHYGGZJOCAFR-MNXVOIDGSA-N 0.000 description 1
- LPFBXFILACZHIB-LAEOZQHASA-N Ile-Gly-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)N LPFBXFILACZHIB-LAEOZQHASA-N 0.000 description 1
- GQKSJYINYYWPMR-NGZCFLSTSA-N Ile-Gly-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N1CCC[C@@H]1C(=O)O)N GQKSJYINYYWPMR-NGZCFLSTSA-N 0.000 description 1
- YKLOMBNBQUTJDT-HVTMNAMFSA-N Ile-His-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N YKLOMBNBQUTJDT-HVTMNAMFSA-N 0.000 description 1
- LNJLOZYNZFGJMM-DEQVHRJGSA-N Ile-His-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@@H]2C(=O)O)N LNJLOZYNZFGJMM-DEQVHRJGSA-N 0.000 description 1
- TVYWVSJGSHQWMT-AJNGGQMLSA-N Ile-Leu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N TVYWVSJGSHQWMT-AJNGGQMLSA-N 0.000 description 1
- PARSHQDZROHERM-NHCYSSNCSA-N Ile-Lys-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)N PARSHQDZROHERM-NHCYSSNCSA-N 0.000 description 1
- GVNNAHIRSDRIII-AJNGGQMLSA-N Ile-Lys-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N GVNNAHIRSDRIII-AJNGGQMLSA-N 0.000 description 1
- GLYJPWIRLBAIJH-UHFFFAOYSA-N Ile-Lys-Pro Natural products CCC(C)C(N)C(=O)NC(CCCCN)C(=O)N1CCCC1C(O)=O GLYJPWIRLBAIJH-UHFFFAOYSA-N 0.000 description 1
- AKOYRLRUFBZOSP-BJDJZHNGSA-N Ile-Lys-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)N AKOYRLRUFBZOSP-BJDJZHNGSA-N 0.000 description 1
- IALVDKNUFSTICJ-GMOBBJLQSA-N Ile-Met-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)O)N IALVDKNUFSTICJ-GMOBBJLQSA-N 0.000 description 1
- LRAUKBMYHHNADU-DKIMLUQUSA-N Ile-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)CC)CC1=CC=CC=C1 LRAUKBMYHHNADU-DKIMLUQUSA-N 0.000 description 1
- XMYURPUVJSKTMC-KBIXCLLPSA-N Ile-Ser-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N XMYURPUVJSKTMC-KBIXCLLPSA-N 0.000 description 1
- RQJUKVXWAKJDBW-SVSWQMSJSA-N Ile-Ser-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N RQJUKVXWAKJDBW-SVSWQMSJSA-N 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- SUPVSFFZWVOEOI-UHFFFAOYSA-N Leu-Ala-Tyr Natural products CC(C)CC(N)C(=O)NC(C)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 SUPVSFFZWVOEOI-UHFFFAOYSA-N 0.000 description 1
- YOZCKMXHBYKOMQ-IHRRRGAJSA-N Leu-Arg-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOZCKMXHBYKOMQ-IHRRRGAJSA-N 0.000 description 1
- VKOAHIRLIUESLU-ULQDDVLXSA-N Leu-Arg-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O VKOAHIRLIUESLU-ULQDDVLXSA-N 0.000 description 1
- WUFYAPWIHCUMLL-CIUDSAMLSA-N Leu-Asn-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O WUFYAPWIHCUMLL-CIUDSAMLSA-N 0.000 description 1
- RFUBXQQFJFGJFV-GUBZILKMSA-N Leu-Asn-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O RFUBXQQFJFGJFV-GUBZILKMSA-N 0.000 description 1
- OIARJGNVARWKFP-YUMQZZPRSA-N Leu-Asn-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O OIARJGNVARWKFP-YUMQZZPRSA-N 0.000 description 1
- MMEDVBWCMGRKKC-GARJFASQSA-N Leu-Asp-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N MMEDVBWCMGRKKC-GARJFASQSA-N 0.000 description 1
- PVMPDMIKUVNOBD-CIUDSAMLSA-N Leu-Asp-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O PVMPDMIKUVNOBD-CIUDSAMLSA-N 0.000 description 1
- PIHFVNPEAHFNLN-KKUMJFAQSA-N Leu-Cys-Tyr Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N PIHFVNPEAHFNLN-KKUMJFAQSA-N 0.000 description 1
- YVKSMSDXKMSIRX-GUBZILKMSA-N Leu-Glu-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O YVKSMSDXKMSIRX-GUBZILKMSA-N 0.000 description 1
- IWTBYNQNAPECCS-AVGNSLFASA-N Leu-Glu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 IWTBYNQNAPECCS-AVGNSLFASA-N 0.000 description 1
- FEHQLKKBVJHSEC-SZMVWBNQSA-N Leu-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 FEHQLKKBVJHSEC-SZMVWBNQSA-N 0.000 description 1
- HNDWYLYAYNBWMP-AJNGGQMLSA-N Leu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N HNDWYLYAYNBWMP-AJNGGQMLSA-N 0.000 description 1
- JNDYEOUZBLOVOF-AVGNSLFASA-N Leu-Leu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JNDYEOUZBLOVOF-AVGNSLFASA-N 0.000 description 1
- KYIIALJHAOIAHF-KKUMJFAQSA-N Leu-Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 KYIIALJHAOIAHF-KKUMJFAQSA-N 0.000 description 1
- WXUOJXIGOPMDJM-SRVKXCTJSA-N Leu-Lys-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O WXUOJXIGOPMDJM-SRVKXCTJSA-N 0.000 description 1
- KPYAOIVPJKPIOU-KKUMJFAQSA-N Leu-Lys-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O KPYAOIVPJKPIOU-KKUMJFAQSA-N 0.000 description 1
- VCHVSKNMTXWIIP-SRVKXCTJSA-N Leu-Lys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O VCHVSKNMTXWIIP-SRVKXCTJSA-N 0.000 description 1
- WXZOHBVPVKABQN-DCAQKATOSA-N Leu-Met-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)O)N WXZOHBVPVKABQN-DCAQKATOSA-N 0.000 description 1
- DPURXCQCHSQPAN-AVGNSLFASA-N Leu-Pro-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DPURXCQCHSQPAN-AVGNSLFASA-N 0.000 description 1
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 1
- LCNASHSOFMRYFO-WDCWCFNPSA-N Leu-Thr-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(N)=O LCNASHSOFMRYFO-WDCWCFNPSA-N 0.000 description 1
- WGAZVKFCPHXZLO-SZMVWBNQSA-N Leu-Trp-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N WGAZVKFCPHXZLO-SZMVWBNQSA-N 0.000 description 1
- UCRJTSIIAYHOHE-ULQDDVLXSA-N Leu-Tyr-Arg Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N UCRJTSIIAYHOHE-ULQDDVLXSA-N 0.000 description 1
- FBNPMTNBFFAMMH-UHFFFAOYSA-N Leu-Val-Arg Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(=O)NC(C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-UHFFFAOYSA-N 0.000 description 1
- YQFZRHYZLARWDY-IHRRRGAJSA-N Leu-Val-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN YQFZRHYZLARWDY-IHRRRGAJSA-N 0.000 description 1
- FDBTVENULFNTAL-XQQFMLRXSA-N Leu-Val-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N FDBTVENULFNTAL-XQQFMLRXSA-N 0.000 description 1
- RVOMPSJXSRPFJT-DCAQKATOSA-N Lys-Ala-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVOMPSJXSRPFJT-DCAQKATOSA-N 0.000 description 1
- WQWZXKWOEVSGQM-DCAQKATOSA-N Lys-Ala-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN WQWZXKWOEVSGQM-DCAQKATOSA-N 0.000 description 1
- UWKNTTJNVSYXPC-CIUDSAMLSA-N Lys-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN UWKNTTJNVSYXPC-CIUDSAMLSA-N 0.000 description 1
- WXJKFRMKJORORD-DCAQKATOSA-N Lys-Arg-Ala Chemical compound NC(=N)NCCC[C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CCCCN WXJKFRMKJORORD-DCAQKATOSA-N 0.000 description 1
- DGAAQRAUOFHBFJ-CIUDSAMLSA-N Lys-Asn-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O DGAAQRAUOFHBFJ-CIUDSAMLSA-N 0.000 description 1
- ABHIXYDMILIUKV-CIUDSAMLSA-N Lys-Asn-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ABHIXYDMILIUKV-CIUDSAMLSA-N 0.000 description 1
- FACUGMGEFUEBTI-SRVKXCTJSA-N Lys-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN FACUGMGEFUEBTI-SRVKXCTJSA-N 0.000 description 1
- FLCMXEFCTLXBTL-DCAQKATOSA-N Lys-Asp-Arg Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N FLCMXEFCTLXBTL-DCAQKATOSA-N 0.000 description 1
- IWWMPCPLFXFBAF-SRVKXCTJSA-N Lys-Asp-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O IWWMPCPLFXFBAF-SRVKXCTJSA-N 0.000 description 1
- RLZDUFRBMQNYIJ-YUMQZZPRSA-N Lys-Cys-Gly Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)O)N RLZDUFRBMQNYIJ-YUMQZZPRSA-N 0.000 description 1
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 1
- UETQMSASAVBGJY-QWRGUYRKSA-N Lys-Gly-His Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CNC=N1 UETQMSASAVBGJY-QWRGUYRKSA-N 0.000 description 1
- NKKFVJRLCCUJNA-QWRGUYRKSA-N Lys-Gly-Lys Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN NKKFVJRLCCUJNA-QWRGUYRKSA-N 0.000 description 1
- VLMNBMFYRMGEMB-QWRGUYRKSA-N Lys-His-Gly Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CNC=N1 VLMNBMFYRMGEMB-QWRGUYRKSA-N 0.000 description 1
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 1
- VMTYLUGCXIEDMV-QWRGUYRKSA-N Lys-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN VMTYLUGCXIEDMV-QWRGUYRKSA-N 0.000 description 1
- JQSIGLHQNSZZRL-KKUMJFAQSA-N Lys-Lys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N JQSIGLHQNSZZRL-KKUMJFAQSA-N 0.000 description 1
- YXPJCVNIDDKGOE-MELADBBJSA-N Lys-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N)C(=O)O YXPJCVNIDDKGOE-MELADBBJSA-N 0.000 description 1
- ALEVUGKHINJNIF-QEJZJMRPSA-N Lys-Phe-Ala Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 ALEVUGKHINJNIF-QEJZJMRPSA-N 0.000 description 1
- LUTDBHBIHHREDC-IHRRRGAJSA-N Lys-Pro-Lys Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O LUTDBHBIHHREDC-IHRRRGAJSA-N 0.000 description 1
- LKDXINHHSWFFJC-SRVKXCTJSA-N Lys-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)N LKDXINHHSWFFJC-SRVKXCTJSA-N 0.000 description 1
- YKBSXQFZWFXFIB-VOAKCMCISA-N Lys-Thr-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCCN)C(O)=O YKBSXQFZWFXFIB-VOAKCMCISA-N 0.000 description 1
- GILLQRYAWOMHED-DCAQKATOSA-N Lys-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN GILLQRYAWOMHED-DCAQKATOSA-N 0.000 description 1
- WDTLNWHPIPCMMP-AVGNSLFASA-N Met-Arg-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O WDTLNWHPIPCMMP-AVGNSLFASA-N 0.000 description 1
- JACAKCWAOHKQBV-UWVGGRQHSA-N Met-Gly-Lys Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN JACAKCWAOHKQBV-UWVGGRQHSA-N 0.000 description 1
- DJBCKVNHEIJLQA-GMOBBJLQSA-N Met-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCSC)N DJBCKVNHEIJLQA-GMOBBJLQSA-N 0.000 description 1
- HGAJNEWOUHDUMZ-SRVKXCTJSA-N Met-Leu-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O HGAJNEWOUHDUMZ-SRVKXCTJSA-N 0.000 description 1
- CHDYFPCQVUOJEB-ULQDDVLXSA-N Met-Leu-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 CHDYFPCQVUOJEB-ULQDDVLXSA-N 0.000 description 1
- OCRSGGIJBDUXHU-WDSOQIARSA-N Met-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(O)=O)=CNC2=C1 OCRSGGIJBDUXHU-WDSOQIARSA-N 0.000 description 1
- WUYLWZRHRLLEGB-AVGNSLFASA-N Met-Met-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O WUYLWZRHRLLEGB-AVGNSLFASA-N 0.000 description 1
- MQASRXPTQJJNFM-JYJNAYRXSA-N Met-Pro-Phe Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MQASRXPTQJJNFM-JYJNAYRXSA-N 0.000 description 1
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- 108010065395 Neuropep-1 Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- WSXKXSBOJXEZDV-DLOVCJGASA-N Phe-Ala-Asn Chemical compound NC(=O)C[C@@H](C([O-])=O)NC(=O)[C@H](C)NC(=O)[C@@H]([NH3+])CC1=CC=CC=C1 WSXKXSBOJXEZDV-DLOVCJGASA-N 0.000 description 1
- KIAWKQJTSGRCSA-AVGNSLFASA-N Phe-Asn-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KIAWKQJTSGRCSA-AVGNSLFASA-N 0.000 description 1
- MECSIDWUTYRHRJ-KKUMJFAQSA-N Phe-Asn-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O MECSIDWUTYRHRJ-KKUMJFAQSA-N 0.000 description 1
- CTNODEMQIKCZGQ-JYJNAYRXSA-N Phe-Gln-His Chemical compound C([C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=CC=C1 CTNODEMQIKCZGQ-JYJNAYRXSA-N 0.000 description 1
- PSKRILMFHNIUAO-JYJNAYRXSA-N Phe-Glu-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N PSKRILMFHNIUAO-JYJNAYRXSA-N 0.000 description 1
- WEMYTDDMDBLPMI-DKIMLUQUSA-N Phe-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N WEMYTDDMDBLPMI-DKIMLUQUSA-N 0.000 description 1
- KDYPMIZMXDECSU-JYJNAYRXSA-N Phe-Leu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 KDYPMIZMXDECSU-JYJNAYRXSA-N 0.000 description 1
- AUJWXNGCAQWLEI-KBPBESRZSA-N Phe-Lys-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O AUJWXNGCAQWLEI-KBPBESRZSA-N 0.000 description 1
- KLYYKKGCPOGDPE-OEAJRASXSA-N Phe-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O KLYYKKGCPOGDPE-OEAJRASXSA-N 0.000 description 1
- KCIKTPHTEYBXMG-BVSLBCMMSA-N Phe-Trp-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O KCIKTPHTEYBXMG-BVSLBCMMSA-N 0.000 description 1
- SGCZFWSQERRKBD-BQBZGAKWSA-N Pro-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 SGCZFWSQERRKBD-BQBZGAKWSA-N 0.000 description 1
- GDXZRWYXJSGWIV-GMOBBJLQSA-N Pro-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 GDXZRWYXJSGWIV-GMOBBJLQSA-N 0.000 description 1
- KPDRZQUWJKTMBP-DCAQKATOSA-N Pro-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 KPDRZQUWJKTMBP-DCAQKATOSA-N 0.000 description 1
- XJROSHJRQTXWAE-XGEHTFHBSA-N Pro-Cys-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XJROSHJRQTXWAE-XGEHTFHBSA-N 0.000 description 1
- LXLFEIHKWGHJJB-XUXIUFHCSA-N Pro-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 LXLFEIHKWGHJJB-XUXIUFHCSA-N 0.000 description 1
- FKYKZHOKDOPHSA-DCAQKATOSA-N Pro-Leu-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FKYKZHOKDOPHSA-DCAQKATOSA-N 0.000 description 1
- JUJCUYWRJMFJJF-AVGNSLFASA-N Pro-Lys-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1 JUJCUYWRJMFJJF-AVGNSLFASA-N 0.000 description 1
- CDGABSWLRMECHC-IHRRRGAJSA-N Pro-Lys-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O CDGABSWLRMECHC-IHRRRGAJSA-N 0.000 description 1
- RCYUBVHMVUHEBM-RCWTZXSCSA-N Pro-Pro-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RCYUBVHMVUHEBM-RCWTZXSCSA-N 0.000 description 1
- SEZGGSHLMROBFX-CIUDSAMLSA-N Pro-Ser-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O SEZGGSHLMROBFX-CIUDSAMLSA-N 0.000 description 1
- HRIXMVRZRGFKNQ-HJGDQZAQSA-N Pro-Thr-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HRIXMVRZRGFKNQ-HJGDQZAQSA-N 0.000 description 1
- FDMCIBSQRKFSTJ-RHYQMDGZSA-N Pro-Thr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O FDMCIBSQRKFSTJ-RHYQMDGZSA-N 0.000 description 1
- CXGLFEOYCJFKPR-RCWTZXSCSA-N Pro-Thr-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O CXGLFEOYCJFKPR-RCWTZXSCSA-N 0.000 description 1
- RSTWKJFWBKFOFC-JYJNAYRXSA-N Pro-Trp-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(O)=O RSTWKJFWBKFOFC-JYJNAYRXSA-N 0.000 description 1
- FIXILCYTSAUERA-FXQIFTODSA-N Ser-Ala-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FIXILCYTSAUERA-FXQIFTODSA-N 0.000 description 1
- HQTKVSCNCDLXSX-BQBZGAKWSA-N Ser-Arg-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O HQTKVSCNCDLXSX-BQBZGAKWSA-N 0.000 description 1
- QFBNNYNWKYKVJO-DCAQKATOSA-N Ser-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CCCN=C(N)N QFBNNYNWKYKVJO-DCAQKATOSA-N 0.000 description 1
- NRCJWSGXMAPYQX-LPEHRKFASA-N Ser-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)N)C(=O)O NRCJWSGXMAPYQX-LPEHRKFASA-N 0.000 description 1
- UCXDHBORXLVBNC-ZLUOBGJFSA-N Ser-Asn-Cys Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(O)=O UCXDHBORXLVBNC-ZLUOBGJFSA-N 0.000 description 1
- YMEXHZTVKDAKIY-GHCJXIJMSA-N Ser-Asn-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(O)=O YMEXHZTVKDAKIY-GHCJXIJMSA-N 0.000 description 1
- UGJRQLURDVGULT-LKXGYXEUSA-N Ser-Asn-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UGJRQLURDVGULT-LKXGYXEUSA-N 0.000 description 1
- WKLJLEXEENIYQE-SRVKXCTJSA-N Ser-Cys-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O WKLJLEXEENIYQE-SRVKXCTJSA-N 0.000 description 1
- FMDHKPRACUXATF-ACZMJKKPSA-N Ser-Gln-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O FMDHKPRACUXATF-ACZMJKKPSA-N 0.000 description 1
- WBINSDOPZHQPPM-AVGNSLFASA-N Ser-Glu-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N)O WBINSDOPZHQPPM-AVGNSLFASA-N 0.000 description 1
- NNFMANHDYSVNIO-DCAQKATOSA-N Ser-Lys-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NNFMANHDYSVNIO-DCAQKATOSA-N 0.000 description 1
- GVMUJUPXFQFBBZ-GUBZILKMSA-N Ser-Lys-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GVMUJUPXFQFBBZ-GUBZILKMSA-N 0.000 description 1
- PMCMLDNPAZUYGI-DCAQKATOSA-N Ser-Lys-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMCMLDNPAZUYGI-DCAQKATOSA-N 0.000 description 1
- QMCDMHWAKMUGJE-IHRRRGAJSA-N Ser-Phe-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O QMCDMHWAKMUGJE-IHRRRGAJSA-N 0.000 description 1
- NUEHQDHDLDXCRU-GUBZILKMSA-N Ser-Pro-Arg Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NUEHQDHDLDXCRU-GUBZILKMSA-N 0.000 description 1
- ILZAUMFXKSIUEF-SRVKXCTJSA-N Ser-Ser-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ILZAUMFXKSIUEF-SRVKXCTJSA-N 0.000 description 1
- FVFUOQIYDPAIJR-XIRDDKMYSA-N Ser-Trp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CO)N FVFUOQIYDPAIJR-XIRDDKMYSA-N 0.000 description 1
- HAUVENOGHPECML-BPUTZDHNSA-N Ser-Trp-Val Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CO)=CNC2=C1 HAUVENOGHPECML-BPUTZDHNSA-N 0.000 description 1
- PLQWGQUNUPMNOD-KKUMJFAQSA-N Ser-Tyr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O PLQWGQUNUPMNOD-KKUMJFAQSA-N 0.000 description 1
- ODRUTDLAONAVDV-IHRRRGAJSA-N Ser-Val-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ODRUTDLAONAVDV-IHRRRGAJSA-N 0.000 description 1
- GKMYGVQDGVYCPC-IUKAMOBKSA-N Thr-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)N GKMYGVQDGVYCPC-IUKAMOBKSA-N 0.000 description 1
- VOHWDZNIESHTFW-XKBZYTNZSA-N Thr-Glu-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N)O VOHWDZNIESHTFW-XKBZYTNZSA-N 0.000 description 1
- BNGDYRRHRGOPHX-IFFSRLJSSA-N Thr-Glu-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(O)=O BNGDYRRHRGOPHX-IFFSRLJSSA-N 0.000 description 1
- JRAUIKJSEAKTGD-TUBUOCAGSA-N Thr-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N JRAUIKJSEAKTGD-TUBUOCAGSA-N 0.000 description 1
- KZSYAEWQMJEGRZ-RHYQMDGZSA-N Thr-Leu-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O KZSYAEWQMJEGRZ-RHYQMDGZSA-N 0.000 description 1
- ZXIHABSKUITPTN-IXOXFDKPSA-N Thr-Lys-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O ZXIHABSKUITPTN-IXOXFDKPSA-N 0.000 description 1
- NZRUWPIYECBYRK-HTUGSXCWSA-N Thr-Phe-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O NZRUWPIYECBYRK-HTUGSXCWSA-N 0.000 description 1
- WNQJTLATMXYSEL-OEAJRASXSA-N Thr-Phe-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O WNQJTLATMXYSEL-OEAJRASXSA-N 0.000 description 1
- IQPWNQRRAJHOKV-KATARQTJSA-N Thr-Ser-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN IQPWNQRRAJHOKV-KATARQTJSA-N 0.000 description 1
- IEZVHOULSUULHD-XGEHTFHBSA-N Thr-Ser-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O IEZVHOULSUULHD-XGEHTFHBSA-N 0.000 description 1
- TZQWJCGVCIJDMU-HEIBUPTGSA-N Thr-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)O)N)O TZQWJCGVCIJDMU-HEIBUPTGSA-N 0.000 description 1
- UQCNIMDPYICBTR-KYNKHSRBSA-N Thr-Thr-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O UQCNIMDPYICBTR-KYNKHSRBSA-N 0.000 description 1
- ZEJBJDHSQPOVJV-UAXMHLISSA-N Thr-Trp-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZEJBJDHSQPOVJV-UAXMHLISSA-N 0.000 description 1
- MQVGIFJSFFVGFW-XEGUGMAKSA-N Trp-Ala-Glu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O MQVGIFJSFFVGFW-XEGUGMAKSA-N 0.000 description 1
- HYVLNORXQGKONN-NUTKFTJISA-N Trp-Ala-Lys Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O)=CNC2=C1 HYVLNORXQGKONN-NUTKFTJISA-N 0.000 description 1
- ILDJYIDXESUBOE-HSCHXYMDSA-N Trp-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N ILDJYIDXESUBOE-HSCHXYMDSA-N 0.000 description 1
- RRVUOLRWIZXBRQ-IHPCNDPISA-N Trp-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N RRVUOLRWIZXBRQ-IHPCNDPISA-N 0.000 description 1
- RNDWCRUOGGQDKN-UBHSHLNASA-N Trp-Ser-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RNDWCRUOGGQDKN-UBHSHLNASA-N 0.000 description 1
- AKFLVKKWVZMFOT-IHRRRGAJSA-N Tyr-Arg-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O AKFLVKKWVZMFOT-IHRRRGAJSA-N 0.000 description 1
- YGKVNUAKYPGORG-AVGNSLFASA-N Tyr-Asp-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YGKVNUAKYPGORG-AVGNSLFASA-N 0.000 description 1
- USYGMBIIUDLYHJ-GVARAGBVSA-N Tyr-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 USYGMBIIUDLYHJ-GVARAGBVSA-N 0.000 description 1
- AVIQBBOOTZENLH-KKUMJFAQSA-N Tyr-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N AVIQBBOOTZENLH-KKUMJFAQSA-N 0.000 description 1
- CDKZJGMPZHPAJC-ULQDDVLXSA-N Tyr-Leu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDKZJGMPZHPAJC-ULQDDVLXSA-N 0.000 description 1
- MXFPBNFKVBHIRW-BZSNNMDCSA-N Tyr-Lys-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O MXFPBNFKVBHIRW-BZSNNMDCSA-N 0.000 description 1
- SQUMHUZLJDUROQ-YDHLFZDLSA-N Tyr-Val-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O SQUMHUZLJDUROQ-YDHLFZDLSA-N 0.000 description 1
- CCEVJBJLPRNAFH-BVSLBCMMSA-N Tyr-Val-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N CCEVJBJLPRNAFH-BVSLBCMMSA-N 0.000 description 1
- RUCNAYOMFXRIKJ-DCAQKATOSA-N Val-Ala-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RUCNAYOMFXRIKJ-DCAQKATOSA-N 0.000 description 1
- NMANTMWGQZASQN-QXEWZRGKSA-N Val-Arg-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N NMANTMWGQZASQN-QXEWZRGKSA-N 0.000 description 1
- PAPWZOJOLKZEFR-AVGNSLFASA-N Val-Arg-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N PAPWZOJOLKZEFR-AVGNSLFASA-N 0.000 description 1
- BYOHPUZJVXWHAE-BYULHYEWSA-N Val-Asn-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N BYOHPUZJVXWHAE-BYULHYEWSA-N 0.000 description 1
- JLFKWDAZBRYCGX-ZKWXMUAHSA-N Val-Asn-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N JLFKWDAZBRYCGX-ZKWXMUAHSA-N 0.000 description 1
- NYTKXWLZSNRILS-IFFSRLJSSA-N Val-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)N)O NYTKXWLZSNRILS-IFFSRLJSSA-N 0.000 description 1
- XXROXFHCMVXETG-UWVGGRQHSA-N Val-Gly-Val Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXROXFHCMVXETG-UWVGGRQHSA-N 0.000 description 1
- CPGJELLYDQEDRK-NAKRPEOUSA-N Val-Ile-Ala Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(O)=O CPGJELLYDQEDRK-NAKRPEOUSA-N 0.000 description 1
- GVJUTBOZZBTBIG-AVGNSLFASA-N Val-Lys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N GVJUTBOZZBTBIG-AVGNSLFASA-N 0.000 description 1
- WBAJDGWKRIHOAC-GVXVVHGQSA-N Val-Lys-Gln Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O WBAJDGWKRIHOAC-GVXVVHGQSA-N 0.000 description 1
- VPGCVZRRBYOGCD-AVGNSLFASA-N Val-Lys-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O VPGCVZRRBYOGCD-AVGNSLFASA-N 0.000 description 1
- CKTMJBPRVQWPHU-JSGCOSHPSA-N Val-Phe-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)N CKTMJBPRVQWPHU-JSGCOSHPSA-N 0.000 description 1
- JAIZPWVHPQRYOU-ZJDVBMNYSA-N Val-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O JAIZPWVHPQRYOU-ZJDVBMNYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010070944 alanylhistidine Proteins 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010010430 asparagine-proline-alanine Proteins 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010092854 aspartyllysine Proteins 0.000 description 1
- 238000007846 asymmetric PCR Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 108010054813 diprotin B Proteins 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 108010027338 isoleucylcysteine Proteins 0.000 description 1
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010075702 lysyl-valyl-aspartyl-leucine Proteins 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 108010064235 lysylglycine Proteins 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 108700023046 methionyl-leucyl-phenylalanine Proteins 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 108010024607 phenylalanylalanine Proteins 0.000 description 1
- 108010012581 phenylalanylglutamate Proteins 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 108010004914 prolylarginine Proteins 0.000 description 1
- 108010070643 prolylglutamic acid Proteins 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000007320 rich medium Substances 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 108010048397 seryl-lysyl-leucine Proteins 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000007861 thermal asymmetric interlaced PCR Methods 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 108010038745 tryptophylglycine Proteins 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/34—Vector systems having a special element relevant for transcription being a transcription initiation element
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/36—Vector systems having a special element relevant for transcription being a transcription termination element
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to a kind of efficient Transpositional mutation system and construction methods.The present invention construct one kind can efficiently concentrating Transposon mutant, and between mutant strain a kind of repeated low double-mass model Transpositional mutation system and removable swivel base enzyme coding gene simple substance grain Transpositional mutation system.The transposon mutant system that the present invention obtains, which can screen, obtains phenotypic mutation strain, later, the genotype of mutant strain can be quickly determined by chromosome walking technology.
Description
Technical field
The invention belongs to molecular biology field, more particularly it relates to a kind of efficient Transpositional mutation system and
Construction method.
Background technology
Technology applied to yeast random mutation mainly has mutagenesis and ultraviolet mutagenesis, these traditional method of mutagenesis sieves
Obtained mutant strain genotype is selected to be difficult to be identified.And transposon mutant label technique is a kind of according to transposons radom insertion
The characteristic of mutagenesis and the method for mutagenesis of separable unknown gene to grow up.However the existing swivel base in yeast
The problems such as subsystem generally existing transposition efficiency is low, insertion mutation randomness is not strong, operation is relatively complicated so that in yeast
Transposon mutant system cannot get universal application, screening mutant strain and the work progress for studying corresponding gene function are slow
Slowly.
Transposons is one section of moveable DNA fragmentation, it can jump to another position from a position of chromosome or plasmid
It sets.When external source transposon integration enter certain unknown gene promoter region or coding region, so that gene mutation is inactivated and is generated
A kind of new mutant phenotype, carrys out the gene of clonal anergy further according to the known array designed on transposons at this time, and in this, as
Probe, clone obtains originally non-deactivated gene in wild type, to achieve the purpose that identify the unknown gene.Transposons is prominent
Become the effective ways that label technique is decision-orientated study gene, and carries out the assignment of genes gene mapping and its functional study, especially one at present
The prefered method of serial controlling gene research.The design basic principle of transposon tagging is:Only retain on transposons and completes swivel base
The specific fragment of process, while selection markers (such as resistant gene) and reporter is added.The technology have quickly, it is accurate and
The characteristics of with a certain phenotype correlation gene, is found in scale.
The genome sequence of Pichia pastoris has been disclosed, and is predicted out a gene more than 5000.It is wherein most
Gene does not obtain experimental verification, and is noted as assuming that the gene of albumen just has more than 1600.For ease of quick, large area
Genes with unknown function is studied on ground, and efficient swivel base insertion mutation system is established in Pichia pastoris will be with very high practical valence
Value.
Invention content
The purpose of the present invention is to provide a kind of efficient Transpositional mutation system and construction methods.
In the first aspect of the present invention, a kind of double-mass model Transpositional mutation system is provided, using yeast cells as host cell, packet
It includes:
(1) transposase expression cassette is integrated on the genome of yeast cells;With
(2) plasmid being free in yeast cells, the plasmid include:Transposable element;And the plasmid does not include yeast and can know
Other replication site sequence.
In a preference, the transposase expression cassette includes (5 ' → 3 '):Promoter, swivel base enzyme coding gene and
Terminator;Preferably, the promoter is selected from:Induction type checks type promoter.
In another preferred example, the promoter is to check type promoter, including but not limited to selected from the group below to open
Mover:Thiamine checks type promoter PpTHI11p or methionine checks type promoter PpMET3p;Or the promoter is
Inducible promoter, including but not limited to promoter:Methanol inducible promoters PpAOX1p.
In another preferred example, the thiamine checks the nucleotide sequence such as SEQ ID of type promoter PpTHI11p
NO:Shown in 5.
In another preferred example, the methionine checks the nucleotide sequence such as SEQ ID of type promoter PpMET3p
NO:Shown in 6.
In another preferred example, the nucleotide sequence of the methanol inducible promoters PpAOX1p such as SEQ ID NO:
Shown in 14.
In another preferred example, the transposase includes but is not limited to transposase selected from the group below:TcBaseCO
V596A transposases, SBase100X transposases, piggyBac transposases.
In another preferred example, the amino acid sequence of the transposase such as SEQ ID NO:1 or SEQ ID NO:2 institutes
Show;Or the nucleotide sequence of the encoding gene of the transposase such as SEQ ID NO:3 or SEQ ID NO:Shown in 4.
In another preferred example, the transposable element includes the transposon ends repeat region being operatively connected and screening
Marker gene sequence.
In another preferred example, the transposon ends repeat region includes but is not limited to transposons selected from the group below
Terminal repeat domain:(being operatively connected) TcBL/TcBR, (being operatively connected) SBL/SBR;Or the selection markers packet
Include (but not limited to) selection markers selected from the group below:HIS4, blasticidin resistance gene ZeocinR, G-418 resistant genes kanR。
In another preferred example, the TcBL is 5 ' end inverted repeat region of TcBuster transposons;Preferably, its
Nucleotide sequence such as SEQ ID NO:Shown in 7.
In another preferred example, the TcBR is 3 ' inverted terminal repeat sequence of TcBuster transposons;Preferably, its
Nucleotide sequence such as SEQ ID NO:Shown in 8.
In another preferred example, the SBL is 5 ' end inverted repeat region of Sleeping beauty transposons;Compared with
Goodly, nucleotide sequence such as SEQ ID NO:Shown in 9.
In another preferred example, the SBR is 3 ' end inverted repeat region of Sleeping beauty transposons;Compared with
Goodly, nucleotide sequence such as SEQ ID NO:Shown in 10.
In another preferred example, the nucleotide sequence of the expression cassette of the HIS4 such as SEQ ID NO:Shown in 11.
In another aspect of this invention, the kit for building the double-mass model Transpositional mutation system, the examination are provided
Agent box includes:(1) plasmid is helped, including swivel base enzyme coding gene, is integrated on the genome of yeast cells;(2)
Free plasmid, the plasmid include:Transposable element;And the plasmid does not include the identifiable replication site sequence of yeast.
In another preferred example, in the kit further include the one or more of the following group:For plasmid linearization
Enzyme, conversion reagent, yeast cells culture medium, recon indentifying substance, operation instructions.
In another aspect of this invention, the purposes that any double-mass model Transpositional mutation system in front is provided, for into
Row gene mutation obtains the gene of mutation.
In another aspect of this invention, a kind of simple substance grain Transpositional mutation system is provided, using yeast cells as host cell, packet
It includes:The plasmid being free in yeast cells, the plasmid include to be operatively connected:Transposase expression cassette, transposable element, virulence egg
White expression cassette;And the plasmid includes yeast replication element.
In a preference, the amino acid sequence such as SEQ ID NO of the transposase:1 or SEQ ID NO:2 institutes
Show;Or the nucleotide sequence of the encoding gene of the transposase such as SEQ ID NO:3 or SEQ ID NO:Shown in 4.
In another preferred example, the transposable element includes the transposon ends repeat region being operatively connected and screening
Marker gene sequence;Preferably, the transposon ends repeat region includes but is not limited to transposons end selected from the group below
Hold repeat region:(being operatively connected) TcBL/TcBR, (being operatively connected) SBL/SBR;Preferably, the screening mark
Note includes but is not limited to selection markers selected from the group below:HIS4, blasticidin resistance gene ZeocinR, G-418 resistant genes
kanR。
In another preferred example, the virulence protein includes but is not limited to:mazF.
In another preferred example, the nucleotide sequence of the mazF such as SEQ ID NO:Shown in 13.
In another preferred example, the virulence protein is mazF, and the virulence protein expression cassette includes strong induction type
Promoter;Preferably, the strong inducible promoter is PpAOX1p promoters.
In another preferred example, the nucleotide sequence of the PpAOX1p promoters such as SEQ ID NO:Shown in 14.
In another preferred example, the reproduction element is PARS2 reproduction elements.
In another preferred example, the nucleotide sequence of the PARS2 reproduction elements such as SEQ ID NO:Shown in 12.
In another aspect of this invention, the kit for building the simple substance grain Transpositional mutation system, the examination are provided
Agent box includes:Plasmid, the plasmid include to be operatively connected:Transposase expression cassette, transposable element, virulence protein expression cassette;
And the plasmid includes yeast replication element.
In another preferred example, further include the following group in the kit for building simple substance grain Transpositional mutation system
It is one or more:Conversion reagent, yeast cells culture medium, recon indentifying substance, operation instructions.
In another aspect of this invention, the purposes that any simple substance grain Transpositional mutation system in front is provided, for into
Row gene mutation obtains the gene of mutation.
In a preference, the yeast cells includes but is not limited to yeast cells selected from the group below:Finish red ferment
Mother cell, brewing yeast cell, candida cell, Hansenula yeast cell.
The other aspects of the present invention are apparent to those skilled in the art due to this disclosure
's.
Description of the drawings
Fig. 1, pBRZeo-TTcBaseCOV596A carrier figure.
Fig. 2, pBRZeo-MSBase100X carrier figure.
Fig. 3, pBRAmp-TcBHis carrier figure.
Fig. 4, pBRAmp-SBHis carrier figure.
Fig. 5, pTTcBHis4AmazFARS carrier figure.
Fig. 6, pMSBHis4AmazFARS carrier figure.
Fig. 7, strain is covered with histidine defect culture medium YND (His-) screening HIS4 genes.A, it is integrating and is expressing
In the bacterial strain of TcBaseCO V596A transposases, the covering strain screened after pBRAmp-His plasmids is converted far less than conversion
The covering strain screened after pBRAmp-TcBHis plasmids.B, in integrating and expressing the bacterial strain of SBase100X transposases,
The covering strain screened also is considerably less than after conversion pBRAmp-TcBHis plasmids to screen and obtain after conversion pBRAmp-His plasmids
Covering strain.
Two kinds of different Transposon mutants that Fig. 8, hiTail PCR amplification double-mass model system are collected.
A, the agarose gel electrophoresis figure run after the hiTail PCR of TcBuster Transposon mutants;
B, the agarose gel electrophoresis figure run after the hiTail PCR of Sleeping beauty Transposon mutants.
Fig. 9, GS115, GS115+1/100 GS115-GFP-His, GS115+1/10000 GS115-GFP-His and 1/
The growth curve of this four groups of bacterial strains of 10000 GS115-GFP-His.
Figure 10, flow cytomery expression quantity GFP reporter proteins bacterial strain and do not express the bacterial strain content of GFP albumen.
When figure is 12 hours, 36 hours, 82 hours and 100 hours, GS115, GS115+1/100 GS115-GFP-His, GS115+1/
This four groups of bacterial strain composition detections of 10000 GS115-GFP-His and 1/10000 GS115-GFP-His.
In Figure 11, quantitative fluorescent PCR, the DNA of this DNA in four of ACT1, SBL, SBR and SBasecopy~Ct standard curves.
Specific implementation mode
For the present inventor by a large amount of experiment and in-depth study, it based on yeast cells is host cell to construct a kind of
Transpositional mutation system.The system is more specifically divided into double-mass model Transpositional mutation system and plasmid Transpositional mutation system.
An aspect of of the present present invention be constructed in yeast can efficiently concentrating Transposon mutant system, can by the system
A large amount of Transposon mutant is simply and easily collected, this is real to the experiment of conditional filtering functional gene and transposons high-flux sequence
It tests and all brings great convenience and help.
It is another aspect of the invention to provide the methods of structure Pichia pastoris Transposon mutant.The present invention passes through cleverly
Experimental design not only finds that TcBuster and Sleeping beauty transposons is active in Pichia pastoris, also into one for the first time
Step demonstrates integration target site of both transposons in Pichia pastoris, in addition also provides two kinds by the optimization of method
The different transposon mutant system of feature is double-mass model system and single pUC pUC respectively.
Term
As used herein, " promoter " refers to a kind of nucleic acid sequence, is typically found in target gene code sequence
The upstream (5 ' end) of row, can guide nucleic acid sequence to be transcribed into mRNA.Usually, promoter or promoter region provide RNA polymerizations
The recognition site of other factors necessary to enzyme and correct starting transcription.Herein, the promoter or promoter region packet
The active variants of promoter are included, which can be the variant that the allelic variant naturally occurred or non-natural occur.
The variant includes substitution variants, Deletion variants and insert variation.
As used herein, " inducible promoter " can be as needed in specific cells growth phase or particular growth
Under environment, "on" and "off" or "high" and " low " of rapid induction genetic transcription.It, can be by inducible promoter point according to source
For naturally occurring promoter and artificial constructed promoter.
As used herein, described " checking type promoter " is a kind of promoter, generally in rich medium (such as
YPD culture mediums) it is opened when being removed in culture medium or ruing out of corresponding repressor in checking state (or holddown)
Mover will be activated." checking type promoter " can also sometimes be considered as the one kind of " inducible promoter ".
As used herein, " expression cassette " refer to include expression desired polypeptides (in the present invention for allogenic polypeptide or
Mit1 polypeptides) needed for all necessary components gene expression system, usually it includes element:Promoter, coding polypeptide
Gene order, terminator;Additionally alternative is including signal coding sequence etc..These elements are operatively connected.
As used herein, described " being operatively connected " or " operability be connected " refer to two or more nucleic acid regions or
Functional space arrangement of nucleic acid sequence.Such as:Promoter region is placed in the certain bits relative to target gene nucleic acid sequence
It sets so that the transcription of nucleic acid sequence is guided by the promoter region, to which promoter region is " operably connected "
In the nucleic acid sequence.
As used herein, " element " refers to a series of useful functional nucleic acid of some expression for albumen
Sequence, in of the invention, " element " is systematically built to form a kind of nucleic acid construct.The sequence of " element "
Can also include their variant those of provided in the present invention, as long as these variants substantially remain the " member
The function of part ".
As used herein, " yeast cells " includes:Pichia pastoris, brewing yeast cell, Candida, the Chinese
Inferior yeast.
Double-mass model Transpositional mutation system
The present invention provides a kind of double-mass model Transpositional mutation system, which is that host is thin with yeast cells
Born of the same parents, including:(1) transposase expression cassette is integrated on the genome of yeast cells;(2) matter being free in yeast cells
Grain, the plasmid include:Transposable element;And the plasmid does not include the identifiable replication site sequence of yeast.
The characteristics of double-mass model Transpositional mutation system of the present invention, is, transposase coding base is incorporated on Yeast genome
Cause;In addition, there is also a kind of cricoid donor plasmids to be free in yeast, which, which contains transposable element but do not include, ferment
Female identifiable replication site sequence.
As the preferred embodiment of the present invention, the transposase expression cassette includes (5 ' → 3 '):Promoter, transposase coding
Gene and terminator;Preferably, the promoter is selected from:Induction type checks type promoter.
Prompt according to the present invention, those skilled in the art can choose suitable induction type or check type promoter,
Therefore the promoter those of is not limited to illustrate in the embodiment of the present invention, other induction types with similar functions or checks
Type promoter can also be included.As the present invention preferred embodiment, the promoter be check type promoter, including but
It is not limited to promoter selected from the group below:Thiamine checks type promoter PpTHI11p or methionine checks type promoter
PpMET3p.Some other available inducible promoter includes but not limited to promoter selected from the group below:Methanol evoked startup
Sub- PpAOX1p.
As the preferred embodiment of the present invention, in double-mass model system of the present invention, the Transposon System can select
From:TcBuster Transposon Systems or Sleeping beauty Transposon Systems.It is highly preferred that corresponding to TcBuster swivel bases
Subsystem, using TcBaseCOV596A transposases;Corresponding to Sleeping beauty Transposon Systems, using SBase100X
Transposase.TcBaseCOV596A and SBase100X is height optimization, the transposase with height transposition activity.Described turns
The seat variant of enzyme, homologue or the like, as long as can retain transposase activity, can also be applied in the present invention.
The transposable element includes the transposon ends repeat region being operatively connected and riddled basins sequence.Make
For the preferred embodiment of the present invention, the transposon ends repeat region includes but not limited to transposon ends weight selected from the group below
Multiple region:The TcBL/TcBR being operatively connected, the SBL/SBR being operatively connected.
Selection markers can be selected according to actually required, it is however generally that, those skilled in the art are easily obtained properly
Selection markers, therefore selection markers those of are not limited to specifically to enumerate in the present invention.As the present invention preferred embodiment,
The selection markers include but not limited to selection markers selected from the group below:HIS4, blasticidin resistance gene ZeocinR, G-
418 resistant gene kanR。
The present invention also provides the kit for building the double-mass model Transpositional mutation system, wrapped in the kit
It includes:(1) plasmid is helped, including swivel base enzyme coding gene, is integrated on the genome of yeast cells;(2) free plasmid,
The plasmid includes:Transposable element;And the plasmid does not include the identifiable replication site sequence of yeast.In the kit also
It may include:For the enzyme of plasmid linearization, conversion reagent, yeast cells culture medium, recon indentifying substance.In addition, described
It may also include in kit:Operation instructions, consequently facilitating those skilled in the art use.
The present invention also provides the purposes of the double-mass model Transpositional mutation system to be dashed forward for carrying out gene mutation
The gene of change.
The double-mass model Transpositional mutation system of the present invention can be applied to the startup that transposon integration is entered to certain unknown gene
Subregion or coding region make the gene mutation inactivate and generate a kind of new mutant phenotype;Subsequently, it is designed according on transposons
Known array carry out the gene of clonal anergy, and in this, as probe, clone obtains originally non-deactivated gene in wild type,
To achieve the purpose that identify the unknown gene.
The double-mass model Transpositional mutation system of the present invention has the characteristics that repeatability is low, complexity is high, by addition further
After optimizing enrichment method, also there is simple and quick concentration effect, it can be rich under conditions of not coated plate or painting a small amount of screen plate
Collect plant mutant strains up to a million, the subsequent swivel base based on high-flux sequence is facilitated to be inserted into sequencing.
Simple substance grain Transpositional mutation system
The present invention provides a kind of simple substance grain Transpositional mutation system, the system using yeast cells as host cell, including:Trip
From the plasmid in yeast cells, which includes to be operatively connected:Transposase expression cassette, transposable element, virulence protein table
Up to box;And the plasmid includes yeast replication element.
The characteristics of simple substance grain Transpositional mutation system of the present invention, is that dissociated a kind of band yeast replication element in yeast
Cyclic plasmid, and the plasmid simultaneously enzyme coding gene containing swivel base, transposable element and a kind of virulence protein expression cassette.
As the preferred embodiment of the present invention, in list pUC pUC of the present invention, the Transposon System can select
From:TcBuster Transposon Systems or Sleeping beauty Transposon Systems.It is highly preferred that corresponding to TcBuster swivel bases
Subsystem, using TcBaseCOV596A transposases;Corresponding to Sleeping beauty Transposon Systems, using SBase100X
Transposase.TcBaseCOV596A and SBase100X is height optimization, the transposase with height transposition activity.Described turns
The seat variant of enzyme, homologue or the like, as long as can retain transposase activity, can also be applied in the present invention.
As the preferred embodiment of the present invention, in the simple substance grain Transpositional mutation system, the transposable element includes behaviour
The transposon ends repeat region and riddled basins sequence of the property made connection;Preferably, the transposon ends duplicate block
Domain includes but not limited to transposon ends repeat region selected from the group below:It is operatively connected) TcBL/TcBR, it is operatively connected
SBL/SBR.
Selection markers can be selected according to actually required, it is however generally that, those skilled in the art are easily obtained properly
Selection markers, therefore selection markers those of are not limited to specifically to enumerate in the present invention.As the present invention preferred embodiment,
The selection markers include but not limited to selection markers selected from the group below:HIS4, blasticidin resistance gene ZeocinR, G-
418 resistant gene kanR。
Further include virulence protein expression cassette in simple substance grain Transpositional mutation system of the present invention.The virulence protein
It is a kind of mRNA interferases, the albumen in cell body can be inhibited to synthesize by cutting off the ACA sequences of single-stranded mRNA, to reach
To the effect for killing cell.The virulence protein includes:mazF.The variant of the virulence protein, homologue or the like,
As long as can retain identical active, can also be applied in the present invention.
As the preferred embodiment of the present invention, the virulence protein is mazF, also, in the virulence protein expression cassette
In, further include strong inducible promoter;So as to express a large amount of mazF, ensure that the mazF for possessing sufficient dose in cell body comes
Kill cell.Preferably, the strong inducible promoter is PpAOX1p promoters.
In the simple substance grain Transpositional mutation system, have the characteristics that the reproduction element of low copy number can be applied to the present invention
In.Therefore, in the present invention, applicable reproduction element is not limited to those listed in the embodiment of the present invention.As the present invention
Preferred embodiment, the reproduction element be PARS2 reproduction elements.
The present invention also provides the kit for building the simple substance grain Transpositional mutation system, wrapped in the kit
It includes:Plasmid, the plasmid include to be operatively connected:Transposase expression cassette, transposable element, virulence protein expression cassette;And the plasmid
Including yeast replication element.Further include in the described kit for building simple substance grain Transpositional mutation system one of the following group or
It is multinomial:Conversion reagent, yeast cells culture medium, recon indentifying substance.In addition, may also include in the kit:It uses
Specification, consequently facilitating those skilled in the art use.
The present invention also provides the purposes of the simple substance grain Transpositional mutation system to be dashed forward for carrying out gene mutation
The gene of change.
The simple substance grain Transpositional mutation system of the present invention can be applied to the startup that transposon integration is entered to certain unknown gene
Subregion or coding region make the gene mutation inactivate and generate a kind of new mutant phenotype;Subsequently, it is designed according on transposons
Known array carry out the gene of clonal anergy, and in this, as probe, clone obtains originally non-deactivated gene in wild type,
To achieve the purpose that identify the unknown gene.
Single pUC pUC can solve double-mass model system makes mutant strain because there is swivel base enzyme coding gene in vivo
There are unstable inhereditary features.For this purpose, the transposase that the present inventor demonstrates single pUC pUC using quantitative fluorescent PCR encodes
Gene is substantially removed.Another feature of single pUC pUC is the simplicity of operation, it is only necessary to use several different cultures instead
Base can collect a large amount of mutant strain.
According to above-mentioned, the present invention construct one kind can efficiently concentrating Transposon mutant, and repeatability is low between mutant strain
Double-mass model Transpositional mutation system;Also construct a kind of simple substance grain Transpositional mutation system of removable swivel base enzyme coding gene.This hair
The phenotypic mutation strain that bright obtained transposon mutant screening system obtains can quickly be determined by chromosome walking technology and is mutated
The genotype of strain, solves the problems, such as that the genotype of conventional ultra-violet mutagenic fungi is difficult to identify.
Present invention will be further explained below with reference to specific examples.It should be understood that these embodiments are merely to illustrate the present invention
Rather than it limits the scope of the invention.In the following examples, the experimental methods for specific conditions are not specified, usually according to conventional strip
Part such as J. Pehanorm Brookers etc. is write, Molecular Cloning:A Laboratory guide, the third edition, Science Press, the condition described in 2002, or
According to the normal condition proposed by manufacturer.
Material
Used toolenzyme is purchased from NEB (Beijing) Co., Ltd, and specific reaction condition and the method used are joined
Examine product manual.
Following commercialization plasmid and bacterial strain are used for gene cloning and protein expression:Plasmid pGAPZ α A, plasmid
PPIC3.5k, Escherichia coli Top10, Pichi strain GS115 are purchased from Invitrogen companies.
YPD culture mediums:2% peptone, 1% yeast powder, 2% glucose, 2% agar powder;YNB culture mediums:0.67%
YNB;MGY culture mediums:1% glycerine, 0.67%YNB;YND fluid nutrient mediums:1% glucose, 0.67%YNB.
When preparing the above culture medium, 115 DEG C of high pressure sterilization 20min of glucose, methanol adds when in use.Other ingredients
121 DEG C of high pressure sterilization 20min.Solid medium adds 2% agar powder.
The transposase gene TcBase of transposons TcBuster applied in the present inventionCOV596A derives from pGALS-
TcBusterCO V596APlasmid, transposable element repeat end sequence and derive from URA3::actin intron::TcBuster-
ClonNat plasmids (Li X, Ewis H, Hice RH, Malani N, Parker N, Zhou L, Feschotte C, Bushman
FD,Atkinson PW,Craig NL.A resurrected mammalian hAT transposable element and
a closely related insect element are highly active in human cell culture.Proc
Natl Acad Sci U S A.2013Feb 5;110(6):E478-87), the two plasmids are provided by Graig NL.The swivel base
Son from insect red flour beetle (Tribolium cAstaneum), belong to the Buster class transposons of hAT superfamilies.HAT turns
Stand is characterized in:(1) target site that 8bp is generated in transposition event repeats;(2) the short opposing end of 5-27bp repeats;
(3) most of hAT classes transposons are less than 4kb.According to the literature, TcBaseCOThe open reading frame length of V596A is
1911bp.The both ends transposable element TcBHis in the present invention respectively contain one section of inverted repeats TIR, respectively TcBL328,
The bases longs of TcBR250, real inverted repeat are 16bp.In addition it will produce one section of 8bp at the target site of insertion just
To repetitive sequence.TIR has been internally embedded the expression cassette of the histidinol dehydrogenase enzyme coding gene HIS4 of one section of Pichia pastoris.
The transposase SBase100X of the transposons Sleeping beauty applied derives from pCMV (CAT) T7-SB100
Plasmid (M á t é s L1, Chuah MK, Belay E, Jerchow B, Manoj N, Acosta-Sanchez A, Grzela DP,
Schmitt A,Becker K,Matrai J,Ma L,Samara-Kuko E,Gysemans C,Pryputniewicz D,
Miskey C,Fletcher B,VandenDriessche T,Ivics Z,Izsvák Z.Molecular evolution of
a novel hyperactive Sleeping Beauty transposase enables robust stable gene
transfer in vertebrates.Nat Genet.2009Jun;41(6):753-61), transposable element repeats end sequence
From pT2-shp53/GFP4 plasmids, the two plasmids are purchased to Addgene (http://www.addgene.org/).This
The open reading frame length of SBase100X transposases in invention is 1023bp;The both ends transposable element SBHis respectively contain one section
Inverted repeats TIR, respectively 5 ' the end inverted repeat region ends SBL and 3 ' inverted repeat region SBR are really reversed heavy
Multiple bases longs are 27bp.In addition it will produce the direct repetitive sequence of one section of 2bp at the target site of insertion;Inside TIR
It is embedded in the expression cassette of the histidinol dehydrogenase enzyme coding gene HIS4 of one section of Pichia pastoris.
Primer such as table 1 applied in the embodiment of the present invention.
The primer that table 1, the present invention use
The content of present invention is further described below in conjunction with embodiment.It will be understood to those of skill in the art that below
Embodiment be merely to illustrate the present invention, and should not be taken as limiting the scope of the invention.
Embodiment 1, the structure for helping plasmid pBRZeo-TTcBaseCOV596A and pBRZeo-MSBase100X
Pichia pastoris total genomic dna is extracted, pGALS-TcBuster is extractedCO V596A(it is obtained from Johns Hopkins University
Medical college), pCMV (CAT) T7-SB100 (be obtained from Addgene) and pPICZ α A plasmids.
Using Pichia pastoris total genomic dna as template, thiamine is amplified with primer THI11p2-amp-F and THI11p-R
Check type THI11p promoter fragments PpTHI11p-amp;
Methionine, which is amplified, with primer MET3p-amp-F and MET3p-R checks type promoter PpMET3p-amp segments.
With pGALS-TcBusterCO V596AFor template, with primer TcBase-thi11p-F and TcBase-aox1tt-R from
Amplification obtains TcBaseCOV596A coding DNA segments TcBase-thi11p/aox1tt in the Plasmid DNA.
Using pCMV (CAT) T7-SB100 plasmids as template, expanded with primer SBase-met3p-F and SBase-aox1tt-R
Obtain SBase100X encoding gene segments SBase-met3p/aox1tt.
Using pPICZ α plasmids as template, amplifies tape copy initiation site with primer pG-A1-F and pBR-ampr2-R and win
The AOX1TT-Zeocin-pBR322-amp segments of Lay mycin resistant gene expression cassette Zeocin.
Use the seamless integration kit ClonExpress MultiS of Vazyme Biotech Nuo Weizan biotech firms
One Step Cloning Kit, by segment PpTHI11p-amp, segment TcBase-thi11p/aox1tt and segment AOX1TT-
Zeocin-pBR322-amp seamless integrations connection cyclization, obtains pBRZeo-TTcBaseCOV596A plasmids (Fig. 1).
By PpMET3p-amp segments, SBase-met3p/aox1tt segments and AOX1TT-Zeocin-pBR322-amp pieces
Section is seamlessly connected and obtains pBRZeo-MSBase100X (Fig. 2).
Two kinds of connection liquid are converted respectively into Escherichia coli Top10 competence, it is solid with the LB for being added to ampicillin
Body Screening of Media goes out positive transformant, and further amplification cultivation, extracts plasmid.
The structure of embodiment 2, donor plasmid pBRAmp-TcBHis and pBRAmp-SBHis
Extract pPIC3.5k plasmids and URA3::actin intron::TcBuster-ClonNat plasmids (are obtained from John suddenly
Pu Jinsi University Medical Colleges).
Using pPIC3.5k plasmids as template, expand to obtain with primer pG-A2-F and Amp-L1-R respectively multiple with Escherichia coli
The pBR322-Amp segments of element processed amplify HIS4 expression casette segments with His-starg-F and His-starg-R
His4-arg。
With URA3::actin intron::TcBuster-ClonNat plasmids are template, with primer TcBL-amp-F/
TcBL-arg4-R, TcBR-au-F/TcBR-pbr322-R are expanded respectively obtains two end sequences of TcBuster transposable elements
TcBL-amp/arg segments and TcBR-pbr322 segments.
Plasmid pT2-shp53/GFP4 (being obtained from Addgene) is extracted and using the plasmid as template, with primer SBL-amp-F/
SBL-arg4-R, SBR-arg4-F/SBR-pbr322-R are expanded respectively obtains two ends of Sleeping beauty transposable elements
Sequence SBL-amp/arg segments and SBR-pbr322 segments.
By pBR322-Amp segments, TcBL-amp/arg segments, His4-arg segments and seamless group of TcBR-pbr322 segments
Dress up pBRAmp-TcBHis plasmids (Fig. 3).
By pBR322-Amp segments, SBL-amp/arg segments, His4-arg segments and SBR-pbr322 segment seamless integrations
At pBRAmp-SBHis plasmids (Fig. 4).
The structure of embodiment 3, plasmid pTTcBHis4AMazFARS and pMSBHis4AMazFARS
Using Pichia pastoris genome as template, primer PARS2-aox1tt-F/PARS2-R and PpAOX1p-F/ are used respectively
PpAOX1p-R expands to obtain PARS2-aox1tt and PpAOX1p segments.
Using the genome of Escherichia coli Top10 as template, amplified with primer MazF-aox1p-F and MazF-aox1tt-R
MazF-aox1p/aox1tt segments with toxin gene mazF.
Using pPICZ α plasmids as template, primer TEF1p-pars2-F/pBR322-R and pG-A1-F/ are used respectively
AOX1TT-A1-R expands to obtain Zeocin-pBR322-pars2 segments and AOX1TT segments.
Next in the above-mentioned several plasmids built, using pBRZeo-TTcBaseCOV596A plasmids as template, with drawing
Object THI11p2-aox1p-F and AOX1TT-A1-R is amplifiable to obtain the PpTHI11p-TcBase- of the expression cassette containing TcBase
AOX1TT-aox1p segments.Using plasmid pBRZeo-MSBase100X as template, with primer MET3p-aox1p-F and AOX1TT-
A1-R expands to obtain the PpMET3p-SBase-AOX1TT-aox1p segments of the expression cassette containing SBase;With plasmid pBRAmp-TcBHis
For template, TcBuster transposable elements TcBTcBL- is obtained with primer TcBL-pbr322-F and TcBR-aox1tt-F are amplifiable
His4-TcBR-pbr322/aox1tt segments;Using plasmid pBRAmp-SBHis as template, with primer SBL-pbr322-F and SBR-
Aox1tt-F is amplifiable to obtain SB transposable element SBL-His4-SBR-pbr322/aox1tt segments.
By PARS2-aox1tt segments, PpAOX1p segments, MazF-aox1p/aox1tt segments, Zeocin-pBR322-
Pars2 segments, AOX1TT segments, PpTHI11p-TcBase-AOX1TT-aox1p segments and TcBTcBL-His4-TcBR-
Pbr322/aox1tt segments seamless integration is at pTTcBHis4AMazFARS plasmids (Fig. 5).
By PARS2-aox1tt segments, PpAOX1p segments, MazF-aox1p/aox1tt segments Zeocin-pBR322-
Pars2 segments, AOX1TT segments, PpMET3p-SBase-AOX1TT-aox1p segments and SBL-His4-SBR-pbr322/
Aox1tt segments seamless integration is at pMSBHis4AMazFARS plasmids (Fig. 6).
Embodiment 4, double-mass model genealogy of law system collect Transposon mutant
TcBuster Transposon mutants are enriched with:Using Nde I restriction enzymes in plasmid pBRZeo-
After being linearized after the promoter THI11p of TTcBaseCOV596A, which is gone in GS115 competence, YPD cultures
Base recovery culture is applied to the YPD solid mediums for being added to bleomycin after 2 hours, picking Partial Conversion after culture 2~3 days
Its genome is cultivated and extracted, the transformant of the enzyme coding gene of swivel base containing TcBaseCOV596A is verified with primer PCR, obtains sun
Property transformant GS115-pBRZeo-TTcBaseCOV596A.Positive transformant is seeded to 100mL EMM cultures, initial inoculation
Concentration is about 0.3OD600, culture to 1.6OD600GS115-pBRZeo-TTcBaseCOV596A competence is prepared when left and right.Then
By pBRAmp-TcBHis cyclic plasmids electrotransformation to GS115-pBRZeo-TTcBaseCOV596A competence bacterial strains, while with not
PBRAmp-His plasmids with transposable element are applied to shortage group ammonia after 3 hours as a contrast, using YND medium cultures transformant
In the YND solid culture plates of acid, culture picking Partial Conversion culture and extracts its genome as subsequent authentication after 2~3 days
With.
SB Transposon mutants are enriched with:After Sac I restriction enzyme plasmids pBRZeo-SBase100X, by this
Plasmid electricity is gone in GS115 competence, and YPD culture mediums recovery culture is applied to the YPD solids training for being added to bleomycin after 2 hours
Base is supported, culture picking Partial Conversion culture and extracts its genome after 2~3 days, and PCR verifies the volume of transposase containing SBase100X
The transformant of code gene, obtains positive transformant GS115-pBRZeo-MSBase100X.Positive transformant is seeded to 100mL
YND is cultivated, and initial inoculation concentration is about 0.3OD600, culture to 1.6OD600GS115-pBRZeo- is prepared when left and right
MSBase100X competence.Then the pBRAmp-His cyclic plasmids by pBRAmp-SBHis and as a contrast distinguish electrotransformation extremely
GS115-pBRZeo-MSBase100X competence is applied to after 3 hours using YND medium cultures transformant and lacks histidine
In YND solid culture plates, culture 2~3 days after picking Partial Conversion culture and extract its genome as subsequent authentication use.
Embodiment 5, hiTail-PCR verification Transposon mutants and integration site analysis
The postgenome for extracting Transposon mutant to be verified then uses primer TcBR- if it is verification TcB mutant strains
SP1 and LAD1-3 as first round primer, using TcBR-SP2 and LAD0 as the second wheel primer pair target gene group template into
(method is referring to Yao-Guang Liu and Yuanling Chen.2007.High-efficiency for the hot asymmetric PCR of row
thermal asymmetric interlaced PCR for amplification of unknown flanking
sequences.BioTechniques.43:649-656).If it is verification SB swivel base strains, then SBR-SP1 and LAD1-1 is used
As first round primer, using SBR-SP2 and LAD0 as the second wheel primer.
20 plants of TcB mutant strains of the random picking of the present inventor and 20 plants of SB mutant strains, (such as Fig. 8) is surveyed after hiTail-PCR
Then sequence sequencing result and the sequencing of GS115 full genomes is compared, analysis result is as shown in table 2 and table 3.20 plants of TcB
Mutant strain is randomly dispersed in the different loci of four chromosome of Pichia pastoris, and integrates target site and meet document report
The base of centre two of the feature of NNNTANNN, i.e., 8 base target sites of most mutant strains is all TA, other Base comparisons
At random, in addition to MT3# mutant strain particular points, intermediate two bases are TG.And there are 19 plants of difference positions in 20 plants of SB mutant strains to be verified
In the different loci of full-length genome, in addition one plant of bacterial strain is still located at the inside of pBRAmp-SBHis plasmid sequences, does not occur to turn
Seat (false positive mutant strain caused by pBRAmp-SBHis plasmid homologous recombinations to genome, behind can analyze).19 plants of swivel bases
The integration site of mutant strain shows that swivel base target site of the SB transposons in Pichia pastoris is TA sequences, this and document report
It matches.In addition the present inventors have noted that the event ratio for being integrated into gene internal has been more than 50%, imply that the transposons has
Conducive to screening function gene mutation strain.
The transposition integration site information of table 2, TcBuster double-mass model systems
The transposition integration site information of table 3, Sleeping beauty double-mass model systems
The apparent transposition activity analysis of embodiment 6, double-mass model system
Although the plasmid without Pichia pastoris reproduction element will not exist in Pichia pastoris body too long, due to cyclic annular matter
The probability that grain has meeting certain is integrated into Pichia pastoris genome (Cregg JM.DNA-mediated
transformation.Methods Mol Biol.2007;389:27-42), this just makes double-mass model system collect Transpositional mutation
There are certain false positives when strain.As shown in fig. 7, control board has still grown dozens of transformant, it accounts for TcB experimental group bacterial strains
3% or so, account for 10% or so of SB experimental group bacterial strains.This false positive ratio is acceptable, and the present inventor still may be used
With by the transformant number in statistical experiment group come the apparent transposition activity of general estimation double-mass model system.1OD600TcB
Electricity turns liquid (about 5106Strain bacterial strain) apply YND (his-) plate after can grow 1400 or so transformants, thus estimate that TcB's is apparent
Swivel base rate is 2.8 × 10-4, this can be described as considerable efficiency, because the efficiency of electrotransformation is 10 in Pichia pastoris-2It is left
The right side (Cregg JM.DNA-mediated transformation.Methods Mol Biol.2007;389:27-42), it goes out
The influence of electrotransformation, transposition efficiencies of the TcBaseCOV596A in Pichia pastoris is about 10-2.Same method, the present inventor estimate
The apparent transposition efficiency for calculating SB swivel bases is about 4.2 × 10-5。
The Transposon mutant that embodiment 7, liquid enrichment double-mass model system are collected
The advantages of double-mass model system is that transposition event is completed in a short period of time, the positive grown on YND screen plates
Transformant generally is independent Transposon mutant, wherein can to collect complexity in this way high by such the present inventor
Mutation library.However, apparent transposition efficiency existing for double-mass model system is not high, especially SB transposons;It subsequently to collect up to a million
Mutant strain be used for high-flux sequence, if coated plate-board-washing is used to collect, it would be desirable to larger amount of reagent and labour.
In view of the bacterial strain for the donor plasmid for not being transferred to the expression casette containing HIS4, or it is not that turning for transposition integration occurs
Beggar can not grow in the YND fluid nutrient mediums for lacking histidine, and the present inventor attempts first a large amount of electricity and turns donor plasmid, then
It is gone to be enriched with the transposon mutant strain for having covered his with YND fluid nutrient mediums.In order to study the feasibility of this scheme, explore simultaneously
Mutant strain accounting is more than 50% time after liquid enrichment culture, and the present inventor is in advance with having covered his while being transferred to GFP reports
The GS115-GFP-His bacterial strains for accusing albumen (being used for flow cytomery quantity) remove simulation Transposon mutant.With specific reference to
The ratio of GS115-GFP-His bacterial strain mixing wild strains GS115 is different, can be divided into following four groups of experiments:
A) 15OD is taken600GS115 inoculations are in 50mL YND culture mediums.
B) 15OD is taken600GS115 bacterial strains and 15/100OD600GS115-GFP-His inoculations are in 50mL YND culture mediums.
C) 15OD is taken600GS115 bacterial strains and 15/10000OD600GS115-GFP-His inoculations are cultivated in 50mL YND
Base.
D) 15/10000OD is taken600GS115-GFP-His inoculations are in 50mL YND culture mediums.
Above four groups of bacterial strains are put in 30 DEG C of 200rpm shaking tables and are cultivated, it is dense in suitable time sampling survey bacterium, to describe
Growth curve is prepared.In addition, the present inventor was at 12 hours, 36 hours, 82 hours and 100 hours, this four time points additionally take
Sample is used for the number of flow cytomery cell.Growth curve as shown in figure 9, control group GS115 due to being histidine nutrition
Deficiency, slow-growing in YND, culture only has 3.8OD to concentration at 100 hours600Left and right, and no longer increase.And it is another
It is that his covers strain to compare strain GS115-GFP-His, since inoculum concentration is extremely low, so being grown before 30 hours very slow, but is entered pair
Growth rate is exceedingly fast after the number phase, and enters stationary phase at 60 hours, and concentration is more than 20OD600.And it is mixed with GS115 and GS115-
The speed of growth of two kinds of GFP-His experiment strains between two control strains, especially ratio close to Transposon mutant c groups,
The speed of growth before about 42 hours is not distinguished significantly with GS115, but apparent quickening is grown after 42 hours, and
100 hours bacterium are dense to reach 10OD600Left and right.Dense according to control strain GS115 maximum bacterium is 3.8OD600Left and right, the present inventor's estimation exist
100 hours, the GS115-GFP-His bacterial strains accounting of c groups should be more than 60%.Further, the present inventor passes through more accurate
Flow cytometry experiment obtains (Figure 10), when incubation time reaches 100 hours, GS115-GFP-His initial concentration accountings
About 10-2Accounting of the b groups at 100 hours can reach 90% or more, and it is 10 to originate accounting-3C groups at 100 hours
Accounting also reached 82%, reached considerable concentration effect.
So far, the present inventor can remove the Transposon mutant that double-mass model method is collected by this liquid concentration method, be subsequent high pass
The experiment that measurement sequence builds million mutant strain ranks is prepared.
Embodiment 8, double-mass model system collect Transposon mutant
The disadvantage of double-mass model system is to save transposase in Pichia pastoris body.TcBaseCOV596A and
Even if SBase100X checks type promoter PpTHI1p in thiamine respectively and methionine checks the PpMET3p controls of type promoter
Under, added in culture corresponding repressor also can not completely the same transposase activity, also checking condition really in experiment
Under detect swivel base phenomenon.This show double-mass model system collect Transposon mutant there are unstable hidden danger, after this will give
Continuous screening function gene makes troubles.
To solve this problem, the present inventor devises a kind of single pUC pUC (plasmid is as illustrated in Figures 5 and 6).The system
There are several features:
A) transposase and transposable element design meet two conditions of swivel base generation in the same plasmid.
B) above-mentioned plasmid carries Pichia pastoris reproduction element PARS2 so that the plasmid has in Pichia pastoris body self
The function of duplication ensure that the expression time of transposase.
C) there is also the inducible expression boxes of virulence protein mazF for above-mentioned plasmid.The expression cassette is in PpAOX1p promoters
Guaranteed, the bacterial strain with mazF expression cassette plasmids under the conditions of methanol will be unable to growth (Yang J, Jiang W, Yang
S.mazF as a counter-selectable marker for unmarked genetic modification of
Pichia pastoris.FEMS Yeast Res.2009Jun;9(4):600-9).
Specific method is that the present inventor turns pTTcBHis4AMazFARS plasmids or pMSBHis4AMazFARS plasmid electricity
Enter GS115 competence, be coated in the YPD culture plates for being added to bleomycin after recovery, 30 DEG C are cultivated 3 days or so, and then picking turns
It is cultivated in beggar to the YPD for be added to bleomycin, waits for culture to OD600For 5-10 when, first use Tiangeng biochemical technology (Beijing)
The small extraction reagent kit of yeast plasmid (DP112) of Co., Ltd extracts plasmid, then using swivel base enzyme coding gene verify primer into
Row PCR verifications.Twice of the bacterial strain being verified with sterile water wash, by a concentration of 0.5OD of initial inoculation600Inoculum concentration inoculation
To the induced expression for carrying out transposase in secondary medium.TcB transposons uses EMM inducing cultures, and SB transposons uses
YND inducing cultures.During this, transposase can promote the generation of transposition event after being expressed, simultaneously because plasmid
Unstability (Cregg JM.DNA-mediated transformation.Methods Mol Biol.2007;389:27-
42), part bacterial strain can there is a phenomenon where plasmid loss in incubation.When two level incubation time was by 24 hours, bacterial strain is basic
Come into stationary phase.Bacterial strain is cleaned with aqua sterilisa again, and is seeded in methanol medium YNM and carries out induction virulence protein
The expression of mazF, induction time are 20 hours or more.This process can remove the bacterial strain with plasmid, due to transposase expression cassette
On plasmid, it is also achieved that the rejecting of swivel base enzyme coding gene.Further, it is selected by YND screen of the painting without histidine
Transposon mutant.
The copy number of transposable element and transposase in embodiment 9, the single pUC pUC of quantitative fluorescent PCR verification
Quantitative fluorescent PCR can be detected in Pichia pastoris gene copy number (method referring to Xuan, Y.J., X.S.Zhou,
W.W.Zhang,X.Zhang,Z.W.Song,and Y.X.Zhang.2009.An upstream activation sequence
controls the expression of AOX1gene in Pichia pastoris.FEMS Yeast Res.9:1271–
1282) it is, that further whether verification transposase gene has been removed, while analyzing the copy of transposable element in single pUC pUC
Number, the present inventor go detection SBase100X genes and SBHis transposable elements to copy by taking SB transposons as an example, with quantitative fluorescent PCR
Shellfish number.The experimental results showed that (Figure 11), reference gene ACT1, SBL and SBR in transposable element, transposase gene SBase100X
Mark song linear coefficient R2All reach 0.999 or more, has illustrated that the logarithm of the copy number of these DNA and Ct values have very
Good linear relationship.The copy number of DNA can be derived by Ct value results.Final result is as shown in table 4, and SBL and SBR's copies
Shellfish number illustrates that transposable element is mainly present in the form of single copy in yeast 1 or so;And the copy number of SBase100X genes
It is very low, almost 0.001, it is contemplated that experiment it is error, may infer that most SB Transposon mutants are free of
SBase100X genes.
Table 4, the mono- pUC pUCs of Sleeping beauty should quantitative PCR Ct values
All references mentioned in the present invention is incorporated herein by reference, independent just as each document
It is incorporated as with reference to such.In addition, it should also be understood that, after reading the above teachings of the present invention, those skilled in the art can
To be made various changes or modifications to the present invention, such equivalent forms equally fall within model defined by the application the appended claims
It encloses.
Sequence table
<110>East China University of Science
<120>A kind of efficient Transpositional mutation system and construction method
<130> 171934
<160> 59
<170> PatentIn version 3.3
<210> 1
<211> 636
<212> PRT
<213>Artificial sequence
<220>
<221> MISC_FEATURE
<223>The amino acid sequence of TcBaseCO V596A transposases
<400> 1
Met Met Leu Asn Trp Leu Lys Ser Gly Lys Leu Glu Ser Gln Ser Gln
1 5 10 15
Glu Gln Ser Ser Cys Tyr Leu Glu Asn Ser Asn Cys Leu Pro Pro Thr
20 25 30
Leu Asp Ser Thr Asp Ile Ile Gly Glu Glu Asn Lys Ala Gly Thr Thr
35 40 45
Ser Arg Lys Lys Arg Lys Tyr Asp Glu Asp Tyr Leu Asn Phe Gly Phe
50 55 60
Thr Trp Thr Gly Asp Lys Asp Glu Pro Asn Gly Leu Cys Val Ile Cys
65 70 75 80
Glu Gln Val Val Asn Asn Ser Ser Leu Asn Pro Ala Lys Leu Lys Arg
85 90 95
His Leu Asp Thr Lys His Pro Thr Leu Lys Gly Lys Ser Glu Tyr Phe
100 105 110
Lys Arg Lys Cys Asn Glu Leu Asn Gln Lys Lys His Thr Phe Glu Arg
115 120 125
Tyr Val Arg Asp Asp Asn Lys Asn Leu Leu Lys Ala Ser Tyr Leu Val
130 135 140
Ser Leu Arg Ile Ala Lys Gln Gly Glu Ala Tyr Thr Ile Ala Glu Lys
145 150 155 160
Leu Ile Lys Pro Cys Thr Lys Asp Leu Thr Thr Cys Val Phe Gly Glu
165 170 175
Lys Phe Ala Ser Lys Val Asp Leu Val Pro Leu Ser Asp Thr Thr Ile
180 185 190
Ser Arg Arg Ile Glu Asp Met Ser Tyr Phe Cys Glu Ala Val Leu Val
195 200 205
Asn Arg Leu Lys Asn Ala Lys Cys Gly Phe Thr Leu Gln Met Asp Glu
210 215 220
Ser Thr Asp Val Ala Gly Leu Ala Ile Leu Leu Val Phe Val Arg Tyr
225 230 235 240
Ile His Glu Ser Ser Phe Glu Glu Asp Met Leu Phe Cys Lys Ala Leu
245 250 255
Pro Thr Gln Thr Thr Gly Glu Glu Ile Phe Asn Leu Leu Asn Ala Tyr
260 265 270
Phe Glu Lys His Ser Ile Pro Trp Asn Leu Cys Tyr His Ile Cys Thr
275 280 285
Asp Gly Ala Lys Ala Met Val Gly Val Ile Lys Gly Val Ile Ala Arg
290 295 300
Ile Lys Lys Leu Val Pro Asp Ile Lys Ala Ser His Cys Cys Leu His
305 310 315 320
Arg His Ala Leu Ala Val Lys Arg Ile Pro Asn Ala Leu His Glu Val
325 330 335
Leu Asn Asp Ala Val Lys Met Ile Asn Phe Ile Lys Ser Arg Pro Leu
340 345 350
Asn Ala Arg Val Phe Ala Leu Leu Cys Asp Asp Leu Gly Ser Leu His
355 360 365
Lys Asn Leu Leu Leu His Thr Glu Val Arg Trp Leu Ser Arg Gly Lys
370 375 380
Val Leu Thr Arg Phe Trp Glu Leu Arg Asp Glu Ile Arg Ile Phe Phe
385 390 395 400
Asn Glu Arg Glu Phe Ala Gly Lys Leu Asn Asp Thr Ser Trp Leu Gln
405 410 415
Asn Leu Ala Tyr Ile Ala Asp Ile Phe Ser Tyr Leu Asn Glu Val Asn
420 425 430
Leu Ser Leu Gln Gly Pro Asn Ser Thr Ile Phe Lys Val Asn Ser Arg
435 440 445
Ile Asn Ser Ile Lys Ser Lys Leu Lys Leu Trp Glu Glu Cys Ile Thr
450 455 460
Lys Asn Asn Thr Glu Cys Phe Ala Asn Leu Asn Asp Phe Leu Glu Thr
465 470 475 480
Ser Asn Thr Ala Leu Asp Pro Asn Leu Lys Ser Asn Ile Leu Glu His
485 490 495
Leu Asn Gly Leu Lys Asn Thr Phe Leu Glu Tyr Phe Pro Pro Thr Cys
500 505 510
Asn Asn Ile Ser Trp Val Glu Asn Pro Phe Asn Glu Cys Gly Asn Val
515 520 525
Asp Thr Leu Pro Ile Lys Glu Arg Glu Gln Leu Ile Asp Ile Arg Thr
530 535 540
Asp Thr Thr Leu Lys Ser Ser Phe Val Pro Asp Gly Ile Gly Pro Phe
545 550 555 560
Trp Ile Lys Leu Met Asp Glu Phe Pro Glu Ile Ser Lys Arg Ala Val
565 570 575
Lys Glu Leu Met Pro Phe Val Thr Thr Tyr Leu Cys Glu Lys Ser Phe
580 585 590
Ser Val Tyr Ala Ala Thr Lys Thr Lys Tyr Arg Asn Arg Leu Asp Ala
595 600 605
Glu Asp Asp Met Arg Leu Gln Leu Thr Thr Ile His Pro Asp Ile Asp
610 615 620
Asn Leu Cys Asn Asn Lys Gln Ala Gln Lys Ser His
625 630 635
<210> 2
<211> 340
<212> PRT
<213>Artificial sequence
<400> 2
Met Gly Lys Ser Lys Glu Ile Ser Gln Asp Leu Arg Lys Arg Ile Val
1 5 10 15
Asp Leu His Lys Ser Gly Ser Ser Leu Gly Ala Ile Ser Lys Arg Leu
20 25 30
Ala Val Pro Arg Ser Ser Val Gln Thr Ile Val Arg Lys Tyr Lys His
35 40 45
His Gly Thr Thr Gln Pro Ser Tyr Arg Ser Gly Arg Arg Arg Val Leu
50 55 60
Ser Pro Arg Asp Glu Arg Thr Leu Val Arg Lys Val Gln Ile Asn Pro
65 70 75 80
Arg Thr Thr Ala Lys Asp Leu Val Lys Met Leu Glu Glu Thr Gly Thr
85 90 95
Lys Val Ser Ile Ser Thr Val Lys Arg Val Leu Tyr Arg His Asn Leu
100 105 110
Lys Gly His Ser Ala Arg Lys Lys Pro Leu Leu Gln Asn Arg His Lys
115 120 125
Lys Ala Arg Leu Arg Phe Ala Thr Ala His Gly Asp Lys Asp Arg Thr
130 135 140
Phe Trp Arg Asn Val Leu Trp Ser Asp Glu Thr Lys Ile Glu Leu Phe
145 150 155 160
Gly His Asn Asp His Arg Tyr Val Trp Arg Lys Lys Gly Glu Ala Cys
165 170 175
Lys Pro Lys Asn Thr Ile Pro Thr Val Lys His Gly Gly Gly Ser Ile
180 185 190
Met Leu Trp Gly Cys Phe Ala Ala Gly Gly Thr Gly Ala Leu His Lys
195 200 205
Ile Asp Gly Ile Met Asp Ala Val Gln Tyr Val Asp Ile Leu Lys Gln
210 215 220
His Leu Lys Thr Ser Val Arg Lys Leu Lys Leu Gly Arg Lys Trp Val
225 230 235 240
Phe Gln His Asp Asn Asp Pro Lys His Thr Ser Lys Val Val Ala Lys
245 250 255
Trp Leu Lys Asp Asn Lys Val Lys Val Leu Glu Trp Pro Ser Gln Ser
260 265 270
Pro Asp Leu Asn Pro Ile Glu Asn Leu Trp Ala Glu Leu Lys Lys Arg
275 280 285
Val Arg Ala Arg Arg Pro Thr Asn Leu Thr Gln Leu His Gln Leu Cys
290 295 300
Gln Glu Glu Trp Ala Lys Ile His Pro Asn Tyr Cys Gly Lys Leu Val
305 310 315 320
Glu Gly Tyr Pro Lys Arg Leu Thr Gln Val Lys Gln Phe Lys Gly Asn
325 330 335
Ala Thr Lys Tyr
340
<210> 3
<211> 1911
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<223>The coding nucleotide sequence of TcBaseCO V596A transposases
<400> 3
atgatgctga attggctgaa aagcggtaaa cttgagtcac agtcccaaga gcagagcagt 60
tgctaccttg agaacagtaa ttgtctgcca cccactctgg actccacgga tattattggt 120
gaggaaaaca aagctggcac cacaagtcgg aagaagagga agtatgacga ggactacctg 180
aactttgggt ttacctggac aggcgataag gatgaaccca atggactctg cgtgatttgc 240
gagcaggttg tgaacaacag ttcactgaat cccgccaagc ttaaacggca tctcgacaca 300
aagcacccta cactgaaggg gaaaagtgag tacttcaaaa ggaagtgcaa cgagctgaat 360
caaaagaaac ataccttcga aagatatgtg cgcgacgaca acaaaaatct gcttaaggca 420
agctatctgg taagccttcg gatcgccaaa cagggagaag cctatacaat tgctgagaag 480
ttgattaaac cctgcacaaa agacctgacg acctgtgtct ttggtgagaa atttgcctct 540
aaggtagacc tggttccttt gtccgacacc actatcagcc gacgcataga ggacatgagt 600
tatttctgtg aagccgtgct ggtcaaccgc ttgaaaaacg ccaagtgcgg attcactttg 660
cagatggacg agtccaccga cgtagcaggc ctggctattc ttctcgtctt cgtgaggtac 720
atccacgagt cttctttcga ggaggatatg ctgttctgta aagctctgcc tacccagact 780
accggggaag aaatctttaa tctcctcaat gcctactttg agaaacacag catcccatgg 840
aacctctgct atcacatttg cactgacggg gcaaaagcta tggttggagt catcaaaggg 900
gtgattgcga gaatcaaaaa gctcgtccct gacataaagg cgagccattg ttgccttcac 960
cgacatgctc tcgctgtaaa gcgcataccg aatgcccttc acgaggttct gaatgacgca 1020
gtcaagatga tcaattttat taagtcccga ccactcaatg caagagtgtt tgccctgttg 1080
tgcgatgacc ttggaagtct ccataaaaac ctgctcctcc acactgaggt gaggtggttg 1140
tcacggggaa aggttctgac tcgattctgg gagctgcgcg atgagattag gattttcttt 1200
aacgagcgag aattcgccgg gaaactgaac gacacaagtt ggttgcagaa tctcgcgtac 1260
attgcagaca tcttcagcta cctgaatgaa gtcaacctca gcttgcaggg gccaaattcc 1320
accatcttca aggtcaacag caggattaac tctatcaaaa gtaagctgaa actgtgggag 1380
gaatgtatta cgaaaaacaa cactgaatgc ttcgctaacc ttaatgactt ccttgagaca 1440
tccaatactg ccttggatcc caatcttaag tctaatatcc tggagcatct gaacggcctt 1500
aaaaacacct tcctggagta cttcccacct acctgcaaca acatcagctg ggtggaaaat 1560
cctttcaacg agtgcggaaa cgttgataca ttgcctatta aagaaaggga acagctgatc 1620
gatattagga cagataccac actgaagtcc tcattcgtgc ccgacggcat tgggcctttc 1680
tggatcaagc tcatggatga gttccctgag atctccaagc gcgctgtgaa agaacttatg 1740
ccatttgtga ctacatacct ttgtgaaaaa tctttttctg tatacgctgc gactaagacc 1800
aaataccgga accgactcga cgccgaagat gatatgcggc tgcagttgac cacaattcac 1860
cctgatatag ataatttgtg taacaacaag caggcccaga aatctcactg a 1911
<210> 4
<211> 1023
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<223>The coding nucleotide sequence of SBase100X transposases
<400> 4
atgggaaaat caaaagaaat cagccaagac ctcagaaaaa gaattgtaga cctccacaag 60
tctggttcat ccttgggagc aatttccaaa cgcctggcgg taccacgttc atctgtacaa 120
acaatagtac gcaagtataa acaccatggg accacgcagc cgtcataccg ctcaggaagg 180
agacgcgttc tgtctcctag agatgaacgt actttggtgc gaaaagtgca aatcaatccc 240
agaacaacag caaaggacct tgtgaagatg ctggaggaaa caggtacaaa agtatctata 300
tccacagtaa aacgagtcct atatcgacat aacctgaaag gccactcagc aaggaagaag 360
ccactgctcc aaaaccgaca taagaaagcc agactacggt ttgcaactgc acatggggac 420
aaagatcgta ctttttggag aaatgtcctc tggtctgatg aaacaaaaat agaactgttt 480
ggccataatg accatcgtta tgtttggagg aagaaggggg aggcttgcaa gccgaagaac 540
accatcccaa ccgtgaagca cgggggtggc agcatcatgt tgtgggggtg ctttgctgca 600
ggagggactg gtgcacttca caaaatagat ggcatcatgg acgccgtgca gtatgtggat 660
atattgaagc aacatctcaa gacatcagtc aggaagttaa agcttggtcg caaatgggtc 720
ttccaacacg acaatgaccc caagcatact tccaaagttg tggcaaaatg gcttaaggac 780
aacaaagtca aggtattgga gtggccatca caaagccctg acctcaatcc tatagaaaat 840
ttgtgggcag aactgaaaaa gcgtgtgcga gcaaggaggc ctacaaacct gactcagtta 900
caccagctct gtcaggagga atgggccaaa attcacccaa attattgtgg gaagcttgtg 960
gaaggctacc cgaaacgttt gacccaagtt aaacaattta aaggcaatgc taccaaatac 1020
tag 1023
<210> 5
<211> 1089
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<223>The nucleotide sequence of promoter PpTHI11p
<400> 5
caagttccgg tacaagcgtg ctaatatctc caagtgtatc taacgggtct gataatattt 60
gttcaattgc gcaagtcaag cagagtttaa tcttttcagc ttcatcgtca gtgatatttc 120
tcagcccaca gaccaagtca actttggaat ctaacaacct tgttcttaca atgttagaac 180
tcttaagtcg catgccatga tcttcaagct gaattttgtg aaggaggtca aaccccacaa 240
tggcatctag ttgtttagaa tacatgcctt cgacaagtgt ttgagtgtcc aaaatcaaga 300
gctcaaaatt attgaatttg tctgccaata acgccgtaaa ttgattagtg tccagcccac 360
caacaatagg agcacctata gttaattttt cagataaatt taagttatca aggtaaagga 420
gctctaagtt taccccttcc aacagggtta tttgagaact caataaattg ttgaattcaa 480
aaccaattgt ctttgaattc tccactggag cttccttgct gaaattgatt ttgataccat 540
tggcatcaaa gagacccgta tgataactcc ataaaaaggg gagatgatag gccttaaatt 600
catcgttaat ctgcaaattt attcctgaca tgtctttgta aatagttata gttcagaaac 660
tggaattgag ctcaaaaaac tggaatcgag cggatatttg aagattgatg ccttactcat 720
gaattgattg ataagagctc cgtgattcac tctgtcaatg attacccctc tcctacccga 780
tttgggactt tttcttcagt cttggggact ttttttcata tgacttgacc ttgctttccc 840
aatagggaag gactcaccca tggatgatta agtttggatt actcgtttag gaaatagtag 900
ccatgaatca atttgaatca taccatcatg aaatagggtt aggctgtaaa tgcctcaaaa 960
atggctcttg aggctggatt tttgggtatt ggaatgttgg tagcaattgg tataaaaggc 1020
catttgtatt tcactttttt gtccttcata ctttactctt ctcaactttg gaaacttcaa 1080
taaatcatc 1089
<210> 6
<211> 993
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<223>The nucleotide sequence of promoter PpMET3p
<400> 6
ttcaggcaac aggaccctcc ggaagaattt tgaagggtga cgtattggca tatctgggca 60
aaatttcacc cgaattgaat gtcaaaattt ccgagtacat taataacaag tctcacttag 120
atctgtctaa gatacaaatc agggaaacca aggcaagcga acaatctcca tcatcttcag 180
gagataaacc agccaaacct gaaaaacctg ctaagaaaga gcctctaaag atcgagaagg 240
aattgacact atctcaagct tacagtaagg aggccctgca aagattatta actattgcag 300
aacaacatgc atacagtgcc aagctgtacc aagaggattc agaagtgatt gatccactgt 360
ttgaggagat cgttgctcca cctagaaatg ccgaacgatt caaaacacaa tttatcgtca 420
cgccctcaga caatagtgtt tccacattga agcttacctt attagtcaac gagagtatat 480
tggatgccaa gcaaagagct cagttattcc ttgatgaagt caaggatcaa ttgacgcaag 540
ataatggtgg cgtttcgtcg tctccccaac ttgaagagtt attctgagtt gcaacaagtc 600
taagtagtaa gtaattaaac catcatgatc ctatgatcgt gatcattcat taaagcacgg 660
tgtggcaatt attgctaggg agatcgtcac tgtatggtgg cagaattatc tctacaagat 720
gtctcaaagt ccccacaaag cttggaccct ctcatctgta atgcattttc ctgtaactcc 780
ccttagccac acgtcaaggg ctctgaatcc gttgaaaagc tgtggcgtct gccaccttta 840
acgtcttcat gagggatgtg cacgtgatat tgtctttccc ttctctaaag cttcgaaaaa 900
aacgcatctc aatgcgagaa gcagatcgat atatataaag aactagtcca ttgaaagatc 960
tctcaatttc actggaaacc aactcagaaa gaa 993
<210> 7
<211> 328
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<223>TcBuster transposons 5' terminal region TcBL sequences
<400> 7
cagtgttctt caacctgtgt tccgcggaac cctagggttc cacccaaagg ctttcggggt 60
tccgcgagtc attgcttcaa ttcgagagac gtcggccgcg ccgctcttca gaatgcacat 120
gcgtcaatcg gagtttcatg ttgaaacatg ttatccattc gcatagttga cttacactgc 180
acttaacctt aattttcaaa aatatgtaac tgtacttgtg gtcgtagttt tgttgttgtt 240
ttaggtttag acaagcaaag gtaagttaac ttacagtttt aaaataaatt gtattttgtt 300
tgatcctaac ctagaatcgt tcagaaat 328
<210> 8
<211> 250
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<223>TcBuster transposons 3' terminal region TcBR sequences
<400> 8
tttttatttt ttattttata tattatttta tttggaatat ttatcttttt gtttaaagtt 60
tgtttaaata aatgcaaatt taaatcttat ttagagtttt tattaccaaa gcacgggctc 120
accttgttcg taacaagtca acgcagctgt ccctaaaatc tcatctgggt gtattactaa 180
atgaagggtt ccataaaaaa aaatatctcg acaaagggtt ccgccggatg gcaaaggttg 240
aagaacactg 250
<210> 9
<211> 227
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<223>Sleeping Beauty transposons 5' terminal region SBL sequences
<400> 9
cagttgaagt cggaagttta catacactta agttggagtc attaaaactc gtttttcaac 60
tactccacaa atttcttgtt aacaaacaat agttttggca agtcagttag gacatctact 120
ttgtgcatga cacaagtcat ttttccaaca attgtttaca gacagattat ttcacttata 180
attcactgta tcacaattcc agtgggtcag aagtttacat acactaa 227
<210> 10
<211> 228
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<223>Sleeping Beauty transposons 3' terminal region SBR sequences
<400> 10
ttgagtgtat gtaaacttct gacccactgg gaatgtgatg aaagaaataa aagctgaaat 60
gaatcattct ctctactatt attctgatat ttcacattct taaaataaag tggtgatcct 120
aactgaccta agacagggaa tttttactag gattaaatgt caggaattgt gaaaaagtga 180
gtttaaatgt atttggctaa ggtgtatgta aacttccgac ttcaactg 228
<210> 11
<211> 3209
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<223>HIS4 expression casette sequences
<400> 11
tggatgctgt aggcataggc ttggttatgc cggtactgcc gggcctcttg cgggatatcg 60
tccattccga cagcatcgcc agtcactatg gcgtgctgct agcgctatat gcgttgatgc 120
aatttctatg cgcacccgtt ctcggagcac tgtccgaccg ctttggccgc cgcccagtcc 180
tgctcgcttc gctacttgga gccactatcg actacgcgat catggcgacc acacccgtcc 240
tgtggatcta tcgaatctaa atgtaagtta aaatctctaa ataattaaat aagtcccagt 300
ttctccatac gaaccttaac agcattgcgg tgagcatcta gaccttcaac agcagccaga 360
tccatcactg cttggccaat atgtttcagt ccctcaggag ttacgtcttg tgaagtgatg 420
aacttctgga aggttgcagt gttaactccg ctgtattgac gggcatatcc gtacgttggc 480
aaagtgtggt tggtaccgga ggagtaatct ccacaactct ctggagagta ggcaccaaca 540
aacacagatc cagcgtgttg tacttgatca acataagaag aagcattctc gatttgcagg 600
atcaagtgtt caggagcgta ctgattggac atttccaaag cctgctcgta ggttgcaacc 660
gatagggttg tagagtgtgc aatacacttg cgtacaattt caacccttgg caactgcaca 720
gcttggttgt gaacagcatc ttcaattctg gcaagctcct tgtctgtcat atcgacagcc 780
aacagaatca cctgggaatc aataccatgt tcagcttgag acagaaggtc tgaggcaacg 840
aaatctggat cagcgtattt atcagcaata actagaactt cagaaggccc agcaggcatg 900
tcaatactac acagggctga tgtgtcattt tgaaccatca tcttggcagc agtaacgaac 960
tggtttcctg gaccaaatat tttgtcacac ttaggaacag tttctgttcc gtaagccata 1020
gcagctactg cctgggcgcc tcctgctagc acgatacact tagcaccaac cttgtgggca 1080
acgtagatga cttctggggt aagggtacca tccttcttag gtggagatgc aaaaacaatt 1140
tctttgcaac cagcaacttt ggcaggaaca cccagcatca gggaagtgga aggcagaatt 1200
gcggttccac caggaatata gaggccaact ttctcaatag gtcttgcaaa acgagagcag 1260
actacaccag ggcaagtctc aacttgcaac gtctccgtta gttgagcttc atggaatttc 1320
ctgacgttat ctatagagag atcaatggct ctcttaacgt tatctggcaa ttgcataagt 1380
tcctctggga aaggagcttc taacacaggt gtcttcaaag cgactccatc aaacttggca 1440
gttagttcta aaagggcttt gtcaccattt tgacgaacat tgtcgacaat tggtttgact 1500
aattccataa tctgttccgt tttctggata ggacgacgaa gggcatcttc aatttcttgt 1560
gaggaggcct tagaaacgtc aattttgcac aattcaatac gaccttcaga agggacttct 1620
ttaggtttgg attcttcttt aggttgttcc ttggtgtatc ctggcttggc atctcctttc 1680
cttctagtga cctttaggga cttcatatcc aggtttctct ccacctcgtc caacgtcaca 1740
ccgtacttgg cacatctaac taatgcaaaa taaaataagt cagcacattc ccaggctata 1800
tcttccttgg atttagcttc tgcaagttca tcagcttcct ccctaatttt agcgttcaac 1860
aaaacttcgt cgtcaaataa ccgtttggta taagaacctt ctggagcatt gctcttacga 1920
tcccacaagg tggcttccat ggctctaaga ccctttgatt ggccaaaaca ggaagtgcgt 1980
tccaagtgac agaaaccaac acctgtttgt tcaaccacaa atttcaagca gtctccatca 2040
caatccaatt cgatacccag caacttttga gttgctccag atgtagcacc tttataccac 2100
aaaccgtgac gacgagattg gtagactcca gtttgtgtcc ttatagcctc cggaatagac 2160
tttttggacg agtacaccag gcccaacgag taattagaag agtcagccac caaagtagtg 2220
aatagaccat cggggcggtc agtagtcaaa gacgccaaca aaatttcact gacagggaac 2280
tttttgacat cttcagaaag ttcgtattca gtagtcaatt gccgagcatc aataatgggg 2340
attataccag aagcaacagt ggaagtcaca tctaccaact ttgcggtctc agaaaaagca 2400
taaacagttc tactaccgcc attagtgaaa cttttcaaat cgcccagtgg agaagaaaaa 2460
ggcacagcga tactagcatt agcgggcaag gatgcaactt tatcaaccag ggtcctatag 2520
ataaccctag cgcctgggat catcctttgg acaactcttt ctgccaaatc taggtccaaa 2580
atcacttcat tgataccatt attgtacaac ttgagcaagt tgtcgatcag ctcctcaaat 2640
tggtcctctg taacggatga ctcaacttgc acattaactt gaagctcagt cgattgagtg 2700
aacttgatca ggttgtgcag ctggtcagca gcatagggaa acacggcttt tcctaccaaa 2760
ctcaaggaat tatcaaactc tgcaacactt gcgtatgcag gtagcaaggg aaatgtcata 2820
cttgaagtcg gacagtgagt gtagtcttga gaaattctga agccgtattt ttattatcag 2880
tgagtcagtc atcaggagat cctctacgcc ggacgcatcg tggccgacct gcaggggggg 2940
ggggggcgct gaggtctgcc tcgtgaagaa ggtgttgctg actcatacca ggcctgaatc 3000
gccccatcat ccagccagaa agtgagggag ccacggttga tgagagcttt gttgtaggtg 3060
gaccagttgg tgattttgaa cttttgcttt gccacggaac ggtctgcgtt gtcgggaaga 3120
tgcgtgatct gatccttcaa ctcagcaaaa gttcgattta ttcaacaaag ccgccgtccc 3180
gtcaagtcag cgtaatgctc tgccagtgt 3209
<210> 12
<211> 393
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<223>Reproduction element PARS2 sequences
<400> 12
tcgaacatag tccgtccccg ggggaagatt tattgtctca aaaggtcaat ttcatatttt 60
atatgcattc aatacttatt tattattaat ttagcttgac tacgatgcat ataattttaa 120
ttttatttta aattatatac tgaggtaaga gtataactct aaacctaata aatatataat 180
taattatacg caatagttaa accatagatt aattacaact aatcctttcg tactaagttg 240
taatccttta ttgacatttc cctaaagcag atagaaacca tactgtctca cgacgtatta 300
aacccaactc acgtaacctt ttaattgacg aacagtcaaa cccttatcag cgtgtgctac 360
caataggata ggttgagtcg acatcgagga tcc 393
<210> 13
<211> 336
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<223>The nucleotide sequence of virulence protein mazF
<400> 13
atggtaagcc gatacgtacc cgatatgggc gatctgattt gggttgattt tgacccgaca 60
aaaggtagcg agcaagctgg acatcgtcca gctgttgtcc tgagtccttt catgtacaac 120
aacaaaacag gtatgtgtct gtgtgttcct tgtacaacgc aatcaaaagg atatccgttc 180
gaagttgttt tatccggtca ggaacgtgat ggcgtagcgt tagctgatca ggtaaaaagt 240
atcgcctggc gggcaagagg agcaacgaag aaaggaacag ttgccccaga ggaattacaa 300
ctcattaaag ccaaaattaa cgtactgatt gggtaa 336
<210> 14
<211> 942
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<223>The nucleotide sequence of promoter PpAOX1p
<400> 14
cgagatctaa catccaaaga cgaaaggttg aatgaaacct ttttgccatc cgacatccac 60
aggtccattc tcacacataa gtgccaaacg caacaggagg ggatacacta gcagcagacc 120
gttgcaaacg caggacctcc actcctcttc tcctcaacac ccacttttgc catcgaaaaa 180
ccagcccagt tattgggctt gattggagct cgctcattcc aattccttct attaggctac 240
taacaccatg actttattag cctgtctatc ctggcccccc tggcgaggtt catgtttgtt 300
tatttccgaa tgcaacaagc tccgcattac acccgaacat cactccagat gagggctttc 360
tgagtgtggg gtcaaatagt ttcatgttcc ccaaatggcc caaaactgac agtttaaacg 420
ctgtcttgga acctaatatg acaaaagcgt gatctcatcc aagatgaact aagtttggtt 480
cgttgaaatg ctaacggcca gttggtcaaa aagaaacttc caaaagtcgg cataccgttt 540
gtcttgtttg gtattgattg acgaatgctc aaaaataatc tcattaatgc ttagcgcagt 600
ctctctatcg cttctgaacc ccggtgcacc tgtgccgaaa cgcaaatggg gaaacacccg 660
ctttttggat gattatgcat tgtctccaca ttgtatgctt ccaagattct ggtgggaata 720
ctgctgatag cctaacgttc atgatcaaaa tttaactgtt ctaaccccta cttgacagca 780
atatataaac agaaggaagc tgccctgtct taaacctttt tttttatcat cattattagc 840
ttactttcat aattgcgact ggttccaatt gacaagcttt tgattttaac gacttttaac 900
gacaacttga gaagatcaaa aaacaactaa ttattcgaaa cg 942
<210> 15
<211> 39
<212> DNA
<213>Primer
<400> 15
aataacagtt attattcgca agttccggta caagcgtgc 39
<210> 16
<211> 23
<212> DNA
<213>Primer
<400> 16
catgatgatt tattgaagtt tcc 23
<210> 17
<211> 39
<212> DNA
<213>Primer
<400> 17
aaacttcaat aaatcatcat gatgctgaat tggctgaaa 39
<210> 18
<211> 41
<212> DNA
<213>Primer
<400> 18
atgtctaagg ctaaaactta tcagtgagat ttctgggcct g 41
<210> 19
<211> 23
<212> DNA
<213>Primer
<400> 19
taagttttag ccttagacat gac 23
<210> 20
<211> 39
<212> DNA
<213>Primer
<400> 20
cgaataataa ctgttattca tgaccaaaat cccttaacg 39
<210> 21
<211> 38
<212> DNA
<213>Primer
<400> 21
aataacagtt attattcgtt caggcaacag gaccctcc 38
<210> 22
<211> 23
<212> DNA
<213>Primer
<400> 22
catttctttc tgagttggtt tcc 23
<210> 23
<211> 36
<212> DNA
<213>Primer
<400> 23
ccaactcaga aagaaatggg aaaatcaaaa gaaatc 36
<210> 24
<211> 34
<212> DNA
<213>Primer
<400> 24
tctaaggcta aaacttagta tttggtagca ttgc 34
<210> 25
<211> 18
<212> DNA
<213>Primer
<400> 25
tgtgagcaaa aggccagc 18
<210> 26
<211> 26
<212> DNA
<213>Primer
<400> 26
cgaataataa ctgttatttt tcagtg 26
<210> 27
<211> 37
<212> DNA
<213>Primer
<400> 27
ataacagtta ttattcgact ttaggccagt gttcttc 37
<210> 28
<211> 36
<212> DNA
<213>Primer
<400> 28
ggaccttctc gcagaatttc tgaacgattc taggtt 36
<210> 29
<211> 35
<212> DNA
<213>Primer
<400> 29
attctgcgag aaggtcctgg atgctgtagg catag 35
<210> 30
<211> 37
<212> DNA
<213>Primer
<400> 30
cttcgtttgt gcggatcaca ctggcagagc attacgc 37
<210> 31
<211> 34
<212> DNA
<213>Primer
<400> 31
gatccgcaca aacgaagtgt gcagaaaagt tcct 34
<210> 32
<211> 28
<212> DNA
<213>Primer
<400> 32
caagcttttt attttttatt ttatatat 28
<210> 33
<211> 38
<212> DNA
<213>Primer
<400> 33
ctggcctttt gctcacaaag tataaagcag tgttcttc 38
<210> 34
<211> 37
<212> DNA
<213>Primer
<400> 34
ataacagtta ttattcgaat tggagctcgg atcccta 37
<210> 35
<211> 37
<212> DNA
<213>Primer
<400> 35
ggaccttctc gcagaatcta tggctcgtac tctatag 37
<210> 36
<211> 37
<212> DNA
<213>Primer
<400> 36
gatccgcaca aacgaagaga tctagcttgt ggaaggc 37
<210> 37
<211> 37
<212> DNA
<213>Primer
<400> 37
ctggcctttt gctcacagac tctagctaga ggatccc 37
<210> 38
<211> 37
<212> DNA
<213>Primer
<400> 38
ttggatgtta gatctcgcaa gttccggtac aagcgtg 37
<210> 39
<211> 18
<212> DNA
<213>Primer
<400> 39
ggatccgcac aaacgaag 18
<210> 40
<211> 35
<212> DNA
<213>Primer
<400> 40
ttcgtttgtg cggatcctcg aacatagtcc gtccc 35
<210> 41
<211> 19
<212> DNA
<213>Primer
<400> 41
ggatcctcga tgtcgactc 19
<210> 42
<211> 31
<212> DNA
<213>Primer
<400> 42
tcgacatcga ggatccccca cacaccatag c 31
<210> 43
<211> 22
<212> DNA
<213>Primer
<400> 43
gatctcatgc atgaccaaaa tc 22
<210> 44
<211> 37
<212> DNA
<213>Primer
<400> 44
tcatgcatga gatcctttag gccagtgttc ttcaacc 37
<210> 45
<211> 48
<212> DNA
<213>Primer
<400> 45
gaagaacact gctttatact tgtgcttttt ttgttggatc cgcacaaa 48
<210> 46
<211> 36
<212> DNA
<213>Primer
<400> 46
taattattcg aaacgatggt aagccgatac gtaccc 36
<210> 47
<211> 36
<212> DNA
<213>Primer
<400> 47
tgtctaaggc taaaacttac ccaatcagta cgttaa 36
<210> 48
<211> 21
<212> DNA
<213>Primer
<400> 48
cgagatctaa catccaaaga c 21
<210> 49
<211> 20
<212> DNA
<213>Primer
<400> 49
cgtttcgaat aattagttgt 20
<210> 50
<211> 39
<212> DNA
<213>Primer
<400> 50
tttggatgtt agatctcgtt caggcaacag gaccctccg 39
<210> 51
<211> 39
<212> DNA
<213>Primer
<400> 51
ggtcatgcat gagatcaatt ggagctcgga tccctatac 39
<210> 52
<211> 35
<212> DNA
<213>Primer
<400> 52
ccaacaaaaa aagcacgact ctagctagag gatcc 35
<210> 53
<211> 28
<212> DNA
<213>Primer
<220>
<221> misc_feature
<222> (20)..(20)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (22)..(24)
<223> n is a, c, g, or t
<400> 53
acgatggact ccagaggcvn vnnnggaa 28
<210> 54
<211> 29
<212> DNA
<213>Primer
<220>
<221> misc_feature
<222> (21)..(21)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (23)..(25)
<223> n is a, c, g, or t
<400> 54
acgatggact ccagaggcvv nvnnnccaa 29
<210> 55
<211> 24
<212> DNA
<213>Primer
<400> 55
aaagcacggg ctcaccttgt tcgt 24
<210> 56
<211> 25
<212> DNA
<213>Primer
<400> 56
tgtccctaaa atctcatctg ggtgt 25
<210> 57
<211> 25
<212> DNA
<213>Primer
<400> 57
gagtgtatgt aaacttctga cccac 25
<210> 58
<211> 25
<212> DNA
<213>Primer
<400> 58
gtgatcctaa ctgacctaag acagg 25
<210> 59
<211> 18
<212> DNA
<213>Primer
<400> 59
acgatggact ccagaggc 18
Claims (18)
1. a kind of double-mass model Transpositional mutation system, which is characterized in that using yeast cells as host cell, including:
(1) transposase expression cassette is integrated on the genome of yeast cells;With
(2) plasmid being free in yeast cells, the plasmid include:Transposable element;And the plasmid is identifiable not comprising yeast
Replication site sequence.
2. double-mass model Transpositional mutation system as described in claim 1, which is characterized in that the transposase expression cassette includes:
Promoter, swivel base enzyme coding gene and terminator;Preferably, the promoter is selected from:Induction type checks type promoter.
3. double-mass model Transpositional mutation system as claimed in claim 2, which is characterized in that the promoter is to check type startup
Son, including promoter selected from the group below:Thiamine checks type promoter PpTHI11p or methionine checks type promoter
PpMET3p;Or
The promoter is inducible promoter, including promoter:Methanol inducible promoters PpAOX1p.
4. double-mass model Transpositional mutation system as described in claim 1, which is characterized in that the transposase includes being selected from the group
Transposase:TcBaseCOV596A transposases, SBase100X transposases, piggyBac transposases.
5. double-mass model Transpositional mutation system as described in claim 1, which is characterized in that the amino acid sequence of the transposase
Such as SEQ ID NO:1 or SEQ ID NO:Shown in 2;Or the nucleotide sequence of the encoding gene of the transposase such as SEQ ID
NO:3 or SEQ ID NO:Shown in 4.
6. double-mass model Transpositional mutation system as described in claim 1, which is characterized in that the transposable element includes operability
The transposon ends repeat region and riddled basins sequence of connection.
7. double-mass model Transpositional mutation system as claimed in claim 6, which is characterized in that the transposon ends repeat region
Including transposon ends repeat region selected from the group below:TcBL/TcBR, SBL/SBR;Or
The selection markers include selection markers selected from the group below:HIS4, blasticidin resistance gene ZeocinR, G-418 is anti-
Property gene kanR。
8. the kit for building double-mass model Transpositional mutation system described in claim 1, which is characterized in that in the kit
Including:
(1) plasmid is helped, including swivel base enzyme coding gene, is integrated on the genome of yeast cells;With
(2) free plasmid, the plasmid include:Transposable element;And the plasmid does not include the identifiable replication site sequence of yeast.
9. the purposes of any double-mass model Transpositional mutation systems of claim 1-7 is mutated for carrying out gene mutation
Gene.
10. a kind of simple substance grain Transpositional mutation system, which is characterized in that using yeast cells as host cell, including:It is free in yeast
Plasmid in cell, the plasmid include to be operatively connected:Transposase expression cassette, transposable element, virulence protein expression cassette;And
The plasmid includes yeast replication element.
11. simple substance grain Transpositional mutation system as claimed in claim 10, which is characterized in that the amino acid sequence of the transposase
Row such as SEQ ID NO:1 or SEQ ID NO:Shown in 2;Or the nucleotide sequence of the encoding gene of the transposase such as SEQ ID
NO:3 or SEQ ID NO:Shown in 4.
12. simple substance grain Transpositional mutation system as claimed in claim 10, which is characterized in that the transposable element includes operation
Property connection transposon ends repeat region and riddled basins sequence;Preferably, the transposon ends repeat region
Including transposon ends repeat region selected from the group below:TcBL/TcBR, SBL/SBR;Preferably, the selection markers include
Selection markers selected from the group below:HIS4, blasticidin resistance gene ZeocinR, G-418 resistant genes kanR。
13. simple substance grain Transpositional mutation system as claimed in claim 10, which is characterized in that the virulence protein includes being selected from
The virulence protein of the following group:mazF.
14. simple substance grain Transpositional mutation system as claimed in claim 13, which is characterized in that the virulence protein is mazF,
The virulence protein expression cassette includes strong inducible promoter;Preferably, the strong inducible promoter opens for PpAOX1p
Mover.
15. simple substance grain Transpositional mutation system as claimed in claim 10, which is characterized in that the reproduction element is PARS2
Reproduction element.
16. the kit for building simple substance grain Transpositional mutation system according to any one of claims 10, which is characterized in that the kit
Include:Plasmid, the plasmid include to be operatively connected:Transposase expression cassette, transposable element, virulence protein expression cassette;And it should
Plasmid includes yeast replication element.
17. the purposes of any simple substance grain Transpositional mutation systems of claim 10-15 is obtained for carrying out gene mutation
The gene of mutation.
The simple substance as described in 18. double-mass model Transpositional mutation system or claim 10-15 as described in claim 1-7 is any are any
Grain Transpositional mutation system, which is characterized in that the yeast cells includes yeast cells selected from the group below:Pichia pastoris,
Brewing yeast cell, candida cell, Hansenula yeast cell.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710270598.XA CN108728477B (en) | 2017-04-24 | 2017-04-24 | Efficient transposition mutation system and construction method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710270598.XA CN108728477B (en) | 2017-04-24 | 2017-04-24 | Efficient transposition mutation system and construction method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108728477A true CN108728477A (en) | 2018-11-02 |
CN108728477B CN108728477B (en) | 2022-02-22 |
Family
ID=63933865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710270598.XA Expired - Fee Related CN108728477B (en) | 2017-04-24 | 2017-04-24 | Efficient transposition mutation system and construction method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108728477B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112626064A (en) * | 2020-11-23 | 2021-04-09 | 天津科技大学 | Construction system of novel transposon mutant strain library |
CN113897342A (en) * | 2021-09-22 | 2022-01-07 | 天津科技大学 | PAP high-specificity coupling enzyme YND mutant based on molecular docking, method and application |
Citations (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1177380A (en) * | 1995-01-23 | 1998-03-25 | 诺沃挪第克公司 | DNA integration by transposition |
EP0955364A2 (en) * | 1998-04-27 | 1999-11-10 | Institute For Molecular Biology And Biotechnology/Forth | Eukaryotic transposable element |
CA2319168A1 (en) * | 1999-10-01 | 2001-04-01 | The Board Of Trustees Of The University Of Illinois | Hyperactive mutants of himar1 transposase and methods for using the same |
WO2001031039A1 (en) * | 1999-10-25 | 2001-05-03 | Invitrogen Corporation | Methods of manipulating and sequencing nucleic acid molecules using transposition and recombination |
EP1161551A2 (en) * | 1999-03-17 | 2001-12-12 | Paradigm Genetics Inc. | Methods and materials for the rapid and high volume production of a gene knock-out library in an organism |
CN1373634A (en) * | 1999-05-17 | 2002-10-09 | 依康遗传学股份有限公司 | Process of rapid variety-independent plant transformation |
US20020199216A1 (en) * | 2001-05-01 | 2002-12-26 | Macrae Amy F. | Use of transposable elements for altering gene expression |
EP1308516A1 (en) * | 2001-10-24 | 2003-05-07 | ADEREGEM (Association pour le Développement de la Recherche en Génétique Moléculaire | Site-directed recombinase fusion proteins and corresponding polynucleotides, vectors and kits, and their uses for site-directed DNA recombination |
JP2003533981A (en) * | 2000-03-23 | 2003-11-18 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | Determination of gene function |
WO2005044975A2 (en) * | 2003-06-12 | 2005-05-19 | E.I. Dupont De Nemours And Company | Genes encoding carotenoid compounds |
US20050124010A1 (en) * | 2000-09-30 | 2005-06-09 | Short Jay M. | Whole cell engineering by mutagenizing a substantial portion of a starting genome combining mutations and optionally repeating |
CN1816621A (en) * | 2003-05-08 | 2006-08-09 | 纳幕尔杜邦公司 | Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from comamonas testosteroni 5-MAGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and |
CN1878785A (en) * | 2003-11-12 | 2006-12-13 | 纳幕尔杜邦公司 | Delta12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast |
CN101195809A (en) * | 2006-12-07 | 2008-06-11 | 中国人民解放军军事医学科学院生物工程研究所 | Pichia pastoris strain with deletion of alpha-1,6-mannose transferase and construction method thereof |
CN101260411A (en) * | 2007-12-17 | 2008-09-10 | 华中农业大学 | Recombination bacillary viral vector skeleton plasmid and application thereof |
CN101372684A (en) * | 2008-07-16 | 2009-02-25 | 南阳师范学院 | Method for easily and efficiently constructing recombinant baculovirus |
US20090172844A1 (en) * | 2003-06-23 | 2009-07-02 | Pioneer Hi-Bred International, Inc. | Engineering single-gene-controlled staygreen potential into plants |
CN101857845A (en) * | 2010-03-05 | 2010-10-13 | 华东理工大学 | Pichia pastoris strain capable of utilizing non methyl alcohol carbon source induced AOX1 promoter to express outside source protein |
CN101935657A (en) * | 2005-02-23 | 2011-01-05 | 格拉茨科技大学 | Mutant AOX 1 promoters |
CN101970638A (en) * | 2007-10-03 | 2011-02-09 | 纳幕尔杜邦公司 | Optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production |
CN102021196A (en) * | 2009-11-20 | 2011-04-20 | 上海杰隆生物工程股份有限公司 | Method for producing recombinant human interleukin-21 by using Pichia pastoris |
US20110117072A1 (en) * | 2007-07-04 | 2011-05-19 | Max-Delbruck-Centrum Fur Molekulare Medizin | Hyperactive variants of the transposase protein of the transposon system sleeping beauty |
CN102154268A (en) * | 2010-12-29 | 2011-08-17 | 复旦大学 | Streptomyces minitype transposable mutation system as well as construction method and application thereof |
CN102216464A (en) * | 2008-08-29 | 2011-10-12 | 纳幕尔杜邦公司 | Manipulation of snf1 protein kinase activity for altered oil content in oleaginous organisms |
CN102286514A (en) * | 2011-07-20 | 2011-12-21 | 中国医学科学院医学实验动物研究所 | Transposition carrier and construction method thereof |
CN202213974U (en) * | 2011-08-03 | 2012-05-09 | 江苏天奇物流系统工程股份有限公司 | Sliding plate conveying system with accompanying lifting function |
CN102559525A (en) * | 2011-12-12 | 2012-07-11 | 江南大学 | Pichia pastoris system coexpressed with aspergillus usamii (Aus) Cell2A and aspergillus oryzae (Aor Xyn11A) |
CN102586268A (en) * | 2011-01-13 | 2012-07-18 | 中国科学院遗传与发育生物学研究所 | Cloning and application of arabidopsis oidium disease resistance suppressor gene EDTS3 |
US20120311742A1 (en) * | 2000-06-16 | 2012-12-06 | Thomas Schmulling | Method for modifying plant morphology, biochemistry and physiology |
CN103468732A (en) * | 2013-07-26 | 2013-12-25 | 吴珍芳 | Expression vector for piggyBac transposon, and transgenic pig and construction method thereof |
CN103764818A (en) * | 2011-08-08 | 2014-04-30 | 埃沃尔瓦公司 | Methods and materials for recombinant production of saffron compounds |
CN103814134A (en) * | 2011-06-21 | 2014-05-21 | 先正达参股股份有限公司 | Recombinant yeast expressing AGT1 |
CN103930550A (en) * | 2011-02-25 | 2014-07-16 | 重组股份有限公司 | Genetically modified animals and methods for making the same |
CN103952404A (en) * | 2014-05-07 | 2014-07-30 | 重庆大学 | Silkworm BmMITE-2 transposon with enhancer effect |
CN103981204A (en) * | 2014-03-24 | 2014-08-13 | 上海海洋大学 | Expression method for active recombination transposase protein of goldfish Tgf2 transposon |
CN103981112A (en) * | 2014-05-21 | 2014-08-13 | 山东大学 | Double-promoter multi-copy recombinant pichia pastoris strain for highly producing endo-inulinase |
CN104404072A (en) * | 2014-11-24 | 2015-03-11 | 浙江大学 | Method for predicting expression quantity of exogenous gene and screening transgenic organism with marker gene |
CN104561080A (en) * | 2015-01-04 | 2015-04-29 | 浙江大学 | Brewing yeast integrated expression vector with recyclable selective marker and construction method thereof |
CN104619835A (en) * | 2012-05-11 | 2015-05-13 | 布特马斯先进生物燃料有限责任公司 | Ketol-acid reductoisomerase enzymes and methods of use |
CN105017428A (en) * | 2014-05-13 | 2015-11-04 | 中国人民解放军军事医学科学院基础医学研究所 | Dual-targeting fusion protein and encoding gene and application thereof |
CN105018523A (en) * | 2015-04-09 | 2015-11-04 | 扬州大学 | ZB (zebrafish) transposon system and gene transfer method mediated by same |
CN105063078A (en) * | 2015-08-03 | 2015-11-18 | 南宁市新科健生物技术有限责任公司 | Construction method of recombinant bacillus subtilis for integration and expression of foreign protein by virtue of Tn7 transposable element |
CN105154473A (en) * | 2015-09-30 | 2015-12-16 | 上海细胞治疗研究院 | Efficient and safe transposable element integration system and application thereof |
CN105524941A (en) * | 2016-01-19 | 2016-04-27 | 扬州大学 | Gene transfer system and method for specific poultry primordial germ cell |
CN105683213A (en) * | 2013-08-08 | 2016-06-15 | 中国科学院遗传与发育生物学研究所 | Bg1 compositions and methods to increase agronomic performance of plants |
US20170101630A1 (en) * | 2014-04-09 | 2017-04-13 | Dna2.0, Inc. | Dna vectors, transposons and transposases for eukaryotic genome modification |
CN106661570A (en) * | 2014-04-10 | 2017-05-10 | 西雅图儿童医院(Dba西雅图儿童研究所) | Production of engineered T-cells by sleeping beauty transposon coupled with methotrexate selection |
CN106755100A (en) * | 2017-02-20 | 2017-05-31 | 李因传 | The genomes of controllability HIV 1 target editing system and its targeting carrier system |
CN107075529A (en) * | 2014-06-05 | 2017-08-18 | 奥西泰克有限公司 | Gene expression system |
CN107400679A (en) * | 2017-07-24 | 2017-11-28 | 中山大学孙逸仙纪念医院 | Plasmid vector and its application for being overexpressed stability series are established based on transposase |
CN107603934A (en) * | 2017-09-11 | 2018-01-19 | 山东大学 | The engineered strain of one plant of heterogenous expression histon deacetylase (HDAC) inhibitor and its application |
CN107723253A (en) * | 2017-09-29 | 2018-02-23 | 天津昕因达生物技术有限公司 | A kind of double-mass model cotransformation foreign gene cance high-expression gene engineering bacteria |
CN107969137A (en) * | 2014-10-17 | 2018-04-27 | 伊卢米纳剑桥有限公司 | Proximity retention swivel base |
CN108004263A (en) * | 2016-11-02 | 2018-05-08 | 清华大学 | A kind of Kluyveromyces marxianus plasmid vector and its application |
CN108587933A (en) * | 2018-01-22 | 2018-09-28 | 中南大学 | Form induction type Yeast engineering bacteria and its construction method |
CN108949869A (en) * | 2017-05-18 | 2018-12-07 | 华东理工大学 | Without carbon repression pichia yeast expression system, its method for building up and application |
CN109072258A (en) * | 2016-02-11 | 2018-12-21 | 地平线探索有限公司 | Replicative transposition subsystem |
WO2019010551A1 (en) * | 2017-07-10 | 2019-01-17 | Instituto De Biologia Molecular Do Paraná - Ibmp | Genetic platform for heterologous overexpression in combination with the selection of cells that produce high levels of proteins |
CN109312361A (en) * | 2016-02-26 | 2019-02-05 | 波赛伊达治疗学股份有限公司 | Transposon System and application method |
CN111328287A (en) * | 2017-07-04 | 2020-06-23 | 库瑞瓦格股份公司 | Novel nucleic acid molecules |
CN111378585A (en) * | 2018-12-28 | 2020-07-07 | 丰益(上海)生物技术研发中心有限公司 | Pichia mutant strain for expressing exogenous gene |
CN111812066A (en) * | 2019-04-10 | 2020-10-23 | 华东理工大学 | Biosensor based on CRISPR/Cas12a system, kit and application of biosensor in small molecule detection |
CN112601583A (en) * | 2018-03-07 | 2021-04-02 | 波赛达治疗公司 | CARTyrin compositions and methods of use |
CN112626064A (en) * | 2020-11-23 | 2021-04-09 | 天津科技大学 | Construction system of novel transposon mutant strain library |
CN112689673A (en) * | 2018-07-11 | 2021-04-20 | 埃克斯基因美国公司 | Transposome-enabled DNA/RNA sequencing (TED RNA-SEQ) |
CN112899296A (en) * | 2019-12-04 | 2021-06-04 | 上海细胞治疗研究院 | Transposase screening report vector and preparation method and application thereof |
CN113439121A (en) * | 2019-02-13 | 2021-09-24 | 普罗拜奥根股份公司 | Transposases with enhanced insertion site selection properties |
-
2017
- 2017-04-24 CN CN201710270598.XA patent/CN108728477B/en not_active Expired - Fee Related
Patent Citations (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1177380A (en) * | 1995-01-23 | 1998-03-25 | 诺沃挪第克公司 | DNA integration by transposition |
EP0955364A2 (en) * | 1998-04-27 | 1999-11-10 | Institute For Molecular Biology And Biotechnology/Forth | Eukaryotic transposable element |
EP1161551A2 (en) * | 1999-03-17 | 2001-12-12 | Paradigm Genetics Inc. | Methods and materials for the rapid and high volume production of a gene knock-out library in an organism |
CN1373634A (en) * | 1999-05-17 | 2002-10-09 | 依康遗传学股份有限公司 | Process of rapid variety-independent plant transformation |
CA2319168A1 (en) * | 1999-10-01 | 2001-04-01 | The Board Of Trustees Of The University Of Illinois | Hyperactive mutants of himar1 transposase and methods for using the same |
WO2001031039A1 (en) * | 1999-10-25 | 2001-05-03 | Invitrogen Corporation | Methods of manipulating and sequencing nucleic acid molecules using transposition and recombination |
JP2003533981A (en) * | 2000-03-23 | 2003-11-18 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | Determination of gene function |
US20030215799A1 (en) * | 2000-03-23 | 2003-11-20 | Sharpe Pamela L. | Method of determination of gene function |
US20120311742A1 (en) * | 2000-06-16 | 2012-12-06 | Thomas Schmulling | Method for modifying plant morphology, biochemistry and physiology |
US20050124010A1 (en) * | 2000-09-30 | 2005-06-09 | Short Jay M. | Whole cell engineering by mutagenizing a substantial portion of a starting genome combining mutations and optionally repeating |
US20020199216A1 (en) * | 2001-05-01 | 2002-12-26 | Macrae Amy F. | Use of transposable elements for altering gene expression |
EP1308516A1 (en) * | 2001-10-24 | 2003-05-07 | ADEREGEM (Association pour le Développement de la Recherche en Génétique Moléculaire | Site-directed recombinase fusion proteins and corresponding polynucleotides, vectors and kits, and their uses for site-directed DNA recombination |
CN1816621A (en) * | 2003-05-08 | 2006-08-09 | 纳幕尔杜邦公司 | Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from comamonas testosteroni 5-MAGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and |
WO2005044975A2 (en) * | 2003-06-12 | 2005-05-19 | E.I. Dupont De Nemours And Company | Genes encoding carotenoid compounds |
US20090172844A1 (en) * | 2003-06-23 | 2009-07-02 | Pioneer Hi-Bred International, Inc. | Engineering single-gene-controlled staygreen potential into plants |
CN1878785A (en) * | 2003-11-12 | 2006-12-13 | 纳幕尔杜邦公司 | Delta12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast |
CN101935657A (en) * | 2005-02-23 | 2011-01-05 | 格拉茨科技大学 | Mutant AOX 1 promoters |
CN101195809A (en) * | 2006-12-07 | 2008-06-11 | 中国人民解放军军事医学科学院生物工程研究所 | Pichia pastoris strain with deletion of alpha-1,6-mannose transferase and construction method thereof |
US20110117072A1 (en) * | 2007-07-04 | 2011-05-19 | Max-Delbruck-Centrum Fur Molekulare Medizin | Hyperactive variants of the transposase protein of the transposon system sleeping beauty |
CN101970638A (en) * | 2007-10-03 | 2011-02-09 | 纳幕尔杜邦公司 | Optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production |
CN101260411A (en) * | 2007-12-17 | 2008-09-10 | 华中农业大学 | Recombination bacillary viral vector skeleton plasmid and application thereof |
CN101372684A (en) * | 2008-07-16 | 2009-02-25 | 南阳师范学院 | Method for easily and efficiently constructing recombinant baculovirus |
CN102216464A (en) * | 2008-08-29 | 2011-10-12 | 纳幕尔杜邦公司 | Manipulation of snf1 protein kinase activity for altered oil content in oleaginous organisms |
CN102021196A (en) * | 2009-11-20 | 2011-04-20 | 上海杰隆生物工程股份有限公司 | Method for producing recombinant human interleukin-21 by using Pichia pastoris |
CN101857845A (en) * | 2010-03-05 | 2010-10-13 | 华东理工大学 | Pichia pastoris strain capable of utilizing non methyl alcohol carbon source induced AOX1 promoter to express outside source protein |
CN102154268A (en) * | 2010-12-29 | 2011-08-17 | 复旦大学 | Streptomyces minitype transposable mutation system as well as construction method and application thereof |
CN102586268A (en) * | 2011-01-13 | 2012-07-18 | 中国科学院遗传与发育生物学研究所 | Cloning and application of arabidopsis oidium disease resistance suppressor gene EDTS3 |
CN103930550A (en) * | 2011-02-25 | 2014-07-16 | 重组股份有限公司 | Genetically modified animals and methods for making the same |
CN103814134A (en) * | 2011-06-21 | 2014-05-21 | 先正达参股股份有限公司 | Recombinant yeast expressing AGT1 |
CN102286514A (en) * | 2011-07-20 | 2011-12-21 | 中国医学科学院医学实验动物研究所 | Transposition carrier and construction method thereof |
CN202213974U (en) * | 2011-08-03 | 2012-05-09 | 江苏天奇物流系统工程股份有限公司 | Sliding plate conveying system with accompanying lifting function |
CN103764818A (en) * | 2011-08-08 | 2014-04-30 | 埃沃尔瓦公司 | Methods and materials for recombinant production of saffron compounds |
CN102559525A (en) * | 2011-12-12 | 2012-07-11 | 江南大学 | Pichia pastoris system coexpressed with aspergillus usamii (Aus) Cell2A and aspergillus oryzae (Aor Xyn11A) |
CN104619835A (en) * | 2012-05-11 | 2015-05-13 | 布特马斯先进生物燃料有限责任公司 | Ketol-acid reductoisomerase enzymes and methods of use |
CN103468732A (en) * | 2013-07-26 | 2013-12-25 | 吴珍芳 | Expression vector for piggyBac transposon, and transgenic pig and construction method thereof |
CN105683213A (en) * | 2013-08-08 | 2016-06-15 | 中国科学院遗传与发育生物学研究所 | Bg1 compositions and methods to increase agronomic performance of plants |
CN103981204A (en) * | 2014-03-24 | 2014-08-13 | 上海海洋大学 | Expression method for active recombination transposase protein of goldfish Tgf2 transposon |
US20170101630A1 (en) * | 2014-04-09 | 2017-04-13 | Dna2.0, Inc. | Dna vectors, transposons and transposases for eukaryotic genome modification |
CN106661570A (en) * | 2014-04-10 | 2017-05-10 | 西雅图儿童医院(Dba西雅图儿童研究所) | Production of engineered T-cells by sleeping beauty transposon coupled with methotrexate selection |
CN103952404A (en) * | 2014-05-07 | 2014-07-30 | 重庆大学 | Silkworm BmMITE-2 transposon with enhancer effect |
CN105017428A (en) * | 2014-05-13 | 2015-11-04 | 中国人民解放军军事医学科学院基础医学研究所 | Dual-targeting fusion protein and encoding gene and application thereof |
CN103981112A (en) * | 2014-05-21 | 2014-08-13 | 山东大学 | Double-promoter multi-copy recombinant pichia pastoris strain for highly producing endo-inulinase |
CN107075529A (en) * | 2014-06-05 | 2017-08-18 | 奥西泰克有限公司 | Gene expression system |
CN107969137A (en) * | 2014-10-17 | 2018-04-27 | 伊卢米纳剑桥有限公司 | Proximity retention swivel base |
CN104404072A (en) * | 2014-11-24 | 2015-03-11 | 浙江大学 | Method for predicting expression quantity of exogenous gene and screening transgenic organism with marker gene |
CN104561080A (en) * | 2015-01-04 | 2015-04-29 | 浙江大学 | Brewing yeast integrated expression vector with recyclable selective marker and construction method thereof |
CN105018523A (en) * | 2015-04-09 | 2015-11-04 | 扬州大学 | ZB (zebrafish) transposon system and gene transfer method mediated by same |
CN105063078A (en) * | 2015-08-03 | 2015-11-18 | 南宁市新科健生物技术有限责任公司 | Construction method of recombinant bacillus subtilis for integration and expression of foreign protein by virtue of Tn7 transposable element |
CN105154473A (en) * | 2015-09-30 | 2015-12-16 | 上海细胞治疗研究院 | Efficient and safe transposable element integration system and application thereof |
CN105524941A (en) * | 2016-01-19 | 2016-04-27 | 扬州大学 | Gene transfer system and method for specific poultry primordial germ cell |
CN109072258A (en) * | 2016-02-11 | 2018-12-21 | 地平线探索有限公司 | Replicative transposition subsystem |
CN109312361A (en) * | 2016-02-26 | 2019-02-05 | 波赛伊达治疗学股份有限公司 | Transposon System and application method |
CN108004263A (en) * | 2016-11-02 | 2018-05-08 | 清华大学 | A kind of Kluyveromyces marxianus plasmid vector and its application |
CN106755100A (en) * | 2017-02-20 | 2017-05-31 | 李因传 | The genomes of controllability HIV 1 target editing system and its targeting carrier system |
CN108949869A (en) * | 2017-05-18 | 2018-12-07 | 华东理工大学 | Without carbon repression pichia yeast expression system, its method for building up and application |
CN111328287A (en) * | 2017-07-04 | 2020-06-23 | 库瑞瓦格股份公司 | Novel nucleic acid molecules |
WO2019010551A1 (en) * | 2017-07-10 | 2019-01-17 | Instituto De Biologia Molecular Do Paraná - Ibmp | Genetic platform for heterologous overexpression in combination with the selection of cells that produce high levels of proteins |
CN107400679A (en) * | 2017-07-24 | 2017-11-28 | 中山大学孙逸仙纪念医院 | Plasmid vector and its application for being overexpressed stability series are established based on transposase |
CN107603934A (en) * | 2017-09-11 | 2018-01-19 | 山东大学 | The engineered strain of one plant of heterogenous expression histon deacetylase (HDAC) inhibitor and its application |
CN107723253A (en) * | 2017-09-29 | 2018-02-23 | 天津昕因达生物技术有限公司 | A kind of double-mass model cotransformation foreign gene cance high-expression gene engineering bacteria |
CN108587933A (en) * | 2018-01-22 | 2018-09-28 | 中南大学 | Form induction type Yeast engineering bacteria and its construction method |
CN112601583A (en) * | 2018-03-07 | 2021-04-02 | 波赛达治疗公司 | CARTyrin compositions and methods of use |
CN112689673A (en) * | 2018-07-11 | 2021-04-20 | 埃克斯基因美国公司 | Transposome-enabled DNA/RNA sequencing (TED RNA-SEQ) |
CN111378585A (en) * | 2018-12-28 | 2020-07-07 | 丰益(上海)生物技术研发中心有限公司 | Pichia mutant strain for expressing exogenous gene |
CN113439121A (en) * | 2019-02-13 | 2021-09-24 | 普罗拜奥根股份公司 | Transposases with enhanced insertion site selection properties |
CN111812066A (en) * | 2019-04-10 | 2020-10-23 | 华东理工大学 | Biosensor based on CRISPR/Cas12a system, kit and application of biosensor in small molecule detection |
CN112899296A (en) * | 2019-12-04 | 2021-06-04 | 上海细胞治疗研究院 | Transposase screening report vector and preparation method and application thereof |
CN112626064A (en) * | 2020-11-23 | 2021-04-09 | 天津科技大学 | Construction system of novel transposon mutant strain library |
Non-Patent Citations (18)
Title |
---|
ANUJ KUMAR 等: "Large-Scale Mutagenesis of the Yeast Genome Using a Tn7-Derived Multipurpose Transposon", 《GENOME RESEARCH》 * |
GUILI SONG 等: "Effective Gene Trapping Mediated by Sleeping Beauty Transposon", 《PLOS ONE》 * |
LAUREN E. WOODARD 等: "Functional analysis of the catalytic triad of the hAT-family transposase TcBuster", 《PLASMID》 * |
MING-BING ZHOU 等: "Transposition of the bamboo Mariner-like element Ppmar1 in yeast", 《MOLECULAR PHYLOGENETICS AND EVOLUTION》 * |
NCBI: "transposase [Cloning vector pT2/Gene-Trap]", 《GENBANK DATABASE》 * |
NCBI: "transposase [Tribolium castaneum]", 《GENBANK DATABASE》 * |
丁昇: "piggyBac转座系统-哺乳动物遗传分析的新工具", 《中国优秀博士学位论文全文数据库(电子期刊)》 * |
倪振华 等: "毕赤酵母重组菌株直接基因缺失方法的研究", 《微生物学通报》 * |
刘向敏: "毛竹MLE转座子转座活性的鉴定与分析", 《中国优秀硕士学位论文全文数据库(电子期刊)农业科技辑》 * |
叶星等: "转基因鱼的研究进展与商业化前景", 《遗传》 * |
张惠展 编著: "《基因工程(第4版)》", 31 January 2017, 华东理工大学出版社 * |
张龙 等: "高效PiggyBac转座酶的构建与筛选", 《西北农林科技大学学报(自然科学版)》 * |
朱锦祥: "基于转座子突变技术的毕赤酵母必须基因鉴定和功能基因筛选", 《中国优秀博士学位论文全文数据库(电子期刊)基础科学辑》 * |
李臻等: "超嗜热古菌整合性遗传元件的研究进展", 《微生物学报》 * |
王志耘 等: "一个链霉菌中微型转座子系统的构建", 《湖北农业科学》 * |
许宁: "毕赤酵母中AOX1启动子调控因子的研究以及新型启动子的鉴定", 《中国优秀硕士学位论文全文数据库(电子期刊)基础科学辑》 * |
郭秀明等: "Tgf2转座子在团头鲂基因组中的插入效率", 《遗传》 * |
马元武 等: "PiggyBac转座酶转基因小鼠模型的建立", 《中国实验动物学报》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112626064A (en) * | 2020-11-23 | 2021-04-09 | 天津科技大学 | Construction system of novel transposon mutant strain library |
CN112626064B (en) * | 2020-11-23 | 2023-02-28 | 天津科技大学 | Construction system of novel transposon mutant strain library |
CN113897342A (en) * | 2021-09-22 | 2022-01-07 | 天津科技大学 | PAP high-specificity coupling enzyme YND mutant based on molecular docking, method and application |
Also Published As
Publication number | Publication date |
---|---|
CN108728477B (en) | 2022-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106480036B (en) | A kind of DNA fragmentation and its application with promoter function | |
CN105316327B (en) | Wheat TaAGO4a gene C RISPR/Cas9 carrier and its application | |
CN110520528A (en) | Hi-fi CAS9 variant and its application | |
CN107012164A (en) | CRISPR/Cpf1 Plant Genome directed modifications functional unit, the carrier comprising the functional unit and its application | |
CN111448313A (en) | Compositions and methods for improving the effectiveness of Cas 9-based knock-in strategies | |
US7968339B2 (en) | Method of inducing genome reorganization via intracellular activation of thermostable multifrequency DNA-cleaving enzyme | |
KR20170099939A (en) | Sequencing control | |
CN110527697A (en) | RNA based on CRISPR-Cas13a pinpoints editing technique | |
US20160289690A1 (en) | Mortierella alpina recombinant gene expression system and construction method and use thereof | |
US6232112B1 (en) | Reagents and methods for diversification of DNA | |
CN106916837B (en) | High osmotic pressure glycerol protein kinase gene RkHog1 and recombinant expression vector thereof | |
CN106589134A (en) | Chimeric protein pAgoE, construction method and applications thereof, chimeric protein pAgoE using guide, and construction method and applications thereof | |
CN112481309B (en) | Application of Ago protein, composition and gene editing method | |
CN108728477A (en) | A kind of efficient Transpositional mutation system and construction method | |
CN109536463A (en) | The dual-gene seamless gene-deleted strain DPV CHv- Δ gE+ Δ gI of duck plague virus gE and gI and its construction method | |
EP1161551A2 (en) | Methods and materials for the rapid and high volume production of a gene knock-out library in an organism | |
CN112899296A (en) | Transposase screening report vector and preparation method and application thereof | |
JP2020534803A (en) | Transposase composition, manufacturing method and screening method | |
Lundblad et al. | Manipulation of cloned yeast DNA | |
JP2009502158A (en) | Methods for identifying genes that increase stress tolerance in yeast and their use for yeast strain improvement | |
CN114163506A (en) | Application of Pseudomonas stutzeri-derived PsPIWI-RE protein in mediating homologous recombination | |
WO2020081958A2 (en) | Compositions and methods for identifying mutations of genes of multi-gene systems having improved function | |
JP2014000076A (en) | Serine palmitoyltransferase | |
CN109293751A (en) | Yersinia pestis virulence-associated protein sORF34 and its encoding gene and application | |
CN109266781B (en) | Fluorescent quantitative reference gene under heat damage stress of Changsha dichroa and primer and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20220222 |